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This thesis focuses on automated contouring of planning CT-scans and 
automated treatment plan generation in radiotherapy to improve treatment 
quality and / or eciency compared to current manual procedures.
For automated contouring we have evaluated a commercially available 
atlas-based autosegmentation tool. With this tool, the CT-scan of a new patient 
can be segmented based on segmented scans of previously treated patients, 
called atlases, thereby signicantly reducing the manual contouring time.
For automated plan generation we have investigated Erasmus-iCycle, an in-house 
developed algorithm for multicriterial beam angle and prole optimization. For 
individual patients, Erasmus-iCycle can fully automatically generate Pareto-optimal 
plans, based on a wish-list with constraints and prioritized objectives specied for 
the corresponding disease / tumor site. Compared to manually generated plans, 
Erasmus-iCycle plans are superior or equal in quality. Moreover, cost savings are 
possible, as time consuming manual planning by dosimetrists can be avoided.
Feasibility of high quality automated contouring and planning has been demonstrated, 
which is also highly relevant for the rapidly evolving eld of adaptive daily re-planning. 
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Propositions accompanying the thesis
Automation of Contouring and Planning in Radiotherapy
1. Although manual editing of autocontours is often required, autocontouring software 
can significantly reduce the overall contouring workload. (this thesis) 
2. In contrast to many other innovations in medicine, automated treatment planning 
can improve treatment quality, while at the same time reducing costs. (this thesis)
3. The value of beam angle optimization and addition of noncoplanar beam directions 
is on average small for head-and-neck cancer patients, yet significant for individual 
cases. (this thesis)
4. In prostate cancer patients with metal hip prostheses, blocking only beam paths 
(beamlets) that transverse metal before reaching the target, instead of the common 
full exclusion of beam directions that include such paths, can improve organ at risk 
sparing to a larger extent than increasing the number of treatment beams. (this thesis) 
5. Fully automated, high quality VMAT planning for prostate cancer patients is feasible 
and has been adopted as a standard clinical routine. (this thesis)
6. Reporting effect sizes may be more informative than reporting p-values.
7. The quality of an espresso is determined by the weakest link in the production chain. 
This is similar to the impact of radiotherapy dose delivery on a serial organ at risk. 
8. Although smoking is bad for human health, taxes on selling tobacco also finances the 
treatment for lung cancer. 
9. Mining of the platinum needed for a particulate filter for a truck diesel engine can 
result in the same amount of pollution as if that same truck would drive around for 
30 years without the particulate filter. 
10. The job contents of radiation dosimetrists differs substantially among countries, 
mainly originating from differences in  responsibilities in the treatment planning 
process. The Dutch system makes practicing the profession attractive.
11. There is a clear relationship between the experienced travel distance and the available 
time. 
Peter W.J. Voet, 12-6-2014
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1.1 Cancer and radiotherapy
¥eWorldHealth Organization (WHO) has identi¡ed cancer as one of the four leading
threats to human health. Cancer is responsible for about 20% of deaths in the European
region, being themost important cause a¥er cardiovascular diseases. InEurope, there are
more than 3million new cases every year. For¥e Netherlands, the Dutch Cancer Soci-
ety has predicted an increase in the total number of new cancer patients from 100.000
in 2011 to 125.000 in 2030. Radiotherapy is one of the main treatment modalities for
cancer, along with surgery and chemotherapy. According to the European Organization
for Radiation Oncology (ESTRO), roughly 50% of all new cancer patients are treated
with radiotherapy. Generally, radiotherapy is used as a local treatment, irradiating body
areas (targets) with proven or suspected disease with ionizing radiation. Most patients
are treated with external beam radiotherapy, using a linear accelerator for generation of
the applied X-rays.
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1.2 Current contouring and external beam radiotherapy
planning in the clinical workDow
¥e goal of radiotherapy is to deliver a high dose of radiation to tumor cells while
minimizing the risk of treatment-induced complications by keeping doses to healthy ra-
diosensitive tissues surrounding the tumor (i.e., organs-at-risk,OARs) as low as possible.
To this purpose, an individualized treatment plan is generated for each patient, aiming
at de¡ning the optimal settings of the treatment unit for the intended treatment. Starting
point for plan generation is an accurate de¡nition of the tumor and OARs in 3 dimen-
sions (contours) in a computer tomography scan (CT-scan) of the patient, acquired prior
to treatment. Plan generation is performed by a dosimetrist in collaboration with the
treating physician, using the treatment prescription as a basis. In this prescription, the
physician de¡nes treatment objectives in terms of dose to be delivered to the tumor and
limitations in doses that may be received by the various OARs. For high dose, curative
treatments, intensitymodulated radiotherapy (IMRT) or volumetricmodulated arc ther-
apy (VMAT) is o¥en used to obtain the best possible dose distribution for the patient.
In order to optimally shape the dose distribution using IMRT (or VMAT), accurate
delineations (contours) of all relevant organs in the planning CT scan are mandatory.
Compared to 3D conformal radiotherapy (3DCRT), IMRT does generally require more
contouring time. For head-and-neck cancer patients, manual contouring of the individ-
ual neck levels I-V [1] (both necks) and 20OARs (salivary glands, chewing and swallow-
ing muscles, and spinal cord/brainstem)may take 3 hours [see Chapter2]).Despite well-
described guidelines formanual contouring of neck levels andOARs [1,2,3,4], contouring
still results in substantial intra- and interobserver variations [5,6,7].
Currently, plan generation is a manual, interactive trial-and-error procedure in
which the dosimetrist tries to steer the treatment planning system (TPS) toward a plan
that satis¡es the treatment prescription, with minimal dose delivery to the most impor-
tant OARs. With this procedure there is no guarantee that, even a¥er many hours of
planningworkload, an alternative approach in steering the TPS so¥warewould not have
resulted in a signi¡cantly improved treatment plan. In other words, it always remains
unclear whether more time and eort should be invested to further search for a better
therapy. On top of this, well-known (substantial) variations in the skills, experience and
drive of planners for generation of high quality treatment plans (even within a single
department), and the quality of interaction of the treating clinician with the planners
may seriously impact plan quality for individual patients. Another frequent threat for
generation of high quality plans in current clinical practice is lack of planning time,
sometimes related to lack of planning resources (personnel orworkstations and so¥ware
licenses). In case of time limitations, even a planner full of ideas andmotivated for further
Outline of the thesis | 5
ch
ap
t e
r1
plan improvement may not be able to achieve the best dose distribution for an individ-
ual patient. Apart from the existing unfavourable variability in plan quality, the current
human factor in plan generation does generally also result in a high cost because of the
involved workload, especially for dicult planning cases with many hours of planning
time.
1.3 Outline of the thesis
¥ework presented in this thesis focuses on automation of 1) contouring in planningCT-
scans and, 2) treatment plan generation.¥e goal is to resolve problemswith the current
manual procedures, as described above.
For autocontouringwe investigated the use of the commercially available atlas-based
autosegmentation so¥ware, ABAS (Elekta). In atlas-based autosegmentation, the CT-
scan of a new patient is segmented using segmented scans of previously treated patients,
called atlases.
¥e basis of the investigations on automated plan generationwas Erasmus-iCycle [8],
an in-house developed algorithm for integrated beam angle and beam pro¡le optimiza-
tion. Erasmus-iCycle automatically generates for each individual patient one or more
Pareto-optimal IMRT plans, based on constraints and prioritized objectives speci¡ed for
the corresponding disease/tumor site.
In chapter 2, we performed a clinical validation study on atlas-based autosegmenta-
tion for target volumes and normal tissues for head-and-neck cancer patients.¥e accu-
racy of ABAS, based on a single and multiple atlases was assessed. Manual contouring
times were compared with the time needed to edit the autocontours.
In chapter 3we investigated the necessity of editing automatically generated contours
for head-and-neck cancer patients by evaluating dosimetric parameters for the neck
levels and OARs in generated treatment plans.
In chapter 4, Erasmus-iCycle was used for automated plan generation in head-and-
neck cancer to compare dierent beam angle selection strategies. 7- and 9-beam equian-
gular beam con¡gurations were compared with 7- and 9-beam plans with optimized
beam angles. In addition to coplanar beam arrangements, noncoplanar beam set-ups
were studied as well.¥e optimal couch angle in coplanar plans was derived to be used
as basic input for volumetric modulated arc therapy (VMAT) planning.
In chapter 5, a prospective clinical study is presented to demonstrate the clinical
6 | Introduction
value of automated treatment planning. For a group of 20 patients, treating physicians
had to choose between a manually optimized IMRT plan, made by dosimetrists, and a
plan based on automatic plan generation with Erasmus-iCycle. For the latter plan, the
Erasmus-iCycle dose distribution was manually reconstructed in the clinical treatment
planning system to obtain a clinically deliverable plan.¥e patient was treated with the
preferred plan.
In chapter 6, Erasmus-iCycle was used to study dierent planning strategies for
prostate cancer patients with metal hip prostheses. Plans with beam directions that fully
avoided the metal prostheses were compared with plans in which all beam directions
were allowed, but parts of the beam irradiating through metal in front of the tumorwere
blocked.¥e investigations did include an assessment of the added value of noncoplanar
beam arrangements.
In chapter 7 we present a method to fully automatically generate clinical treatment
plans for prostate cancer patients, i.e. themanual reconstruction of Erasmus-iCycle plans
by dosimetristswas now also automated (comparewith chapter 5). Fully automated plan
generation was investigated for prostate cancer patients treated with VMAT.
In chapter 8 the results of this thesis are discussed followed by a discussion on future
perspectives.
chapter 2
Clinical validation of atlas-based
autosegmentation of multiple target volumes
and normal tissue (swallowing/mastication)
structures in the head & neck
David N. Teguh,MD, PhD, Peter C. Levendag,MD, PhD, PeterW.J. Voet, RTT,
Abrahim Al-Mamgani,MD, PhD, XiaoHan, PhD,¥eresa K.Wolf, BSc,
Lyndon S.Hibbard, PhD, Peter Nowak,MD, PhD,Ha¡d Akhiat, BSc,
Maarten L.P. Dirkx, PhD, Ben J.M.Heijmen, PhD,Mischa S.Hoogeman, PhD
International Journal of Radiation Oncology Biology Physics; 15:81(4): 950–7 (2011)
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Abstract
Purpose: To validate and clinically evaluate autocontouring by use of atlas-based au-
tosegmentation (ABAS) of computed tomography images.
Methods andMaterials:¥e data from 10 head-and-neck patients were selected as in-
put for ABAS and the neck levels I-V, and 20 organs-at-risk were manually contoured
according to published guidelines.¥e total contouring times were recorded. Two dif-
ferent ABAS strategies, multiple- and single subject, were evaluated and the similarity of
the autocontours with the atlas contours was assessed using Dice coecients and mean
distances, using the leave-one-out method. For 12 clinically treated patients, 5 experi-
enced observers edited the autosegmented contours. ¥e editing times were recorded.
¥eDice coecients andmean distanceswere calculated among clinically used contours,
autocontours and edited autocontours. Finally, an expert panel scored all autocontours as
well as the edited autocontours regarding their adequacy relative to the published atlas.
Results: ¥e time to autosegment all the structures by ABAS was 7 minutes/patient.
No signi¡cant dierences were observed in the autosegmentation accuracy for N0 and
N+ patients. ¥e multi-subject atlas performed best, with a Dice coecient and mean
distance of 0.74 and 2 mm, 0.67 and 3 mm, 0.71 and 2 mm, 0.50 and 2 mm, and 0.78
and 2 mm, for salivary glands, neck levels, chewing muscles, swallowing muscles, and
cord-brainstem, respectively.¥e mean Dice coecient and mean distance of the auto-
contours vs. clinical contourswas 0.8 and 2.4 mm for the neck levels and salivary glands,
respectively. For the autocontours vs. edited autocontours, themeanDice coecient and
mean distance was 0.9 and 1.6 mm, respectively. ¥e expert panel scored 100% of the
autocontours as “minor deviation, editable” or better.¥e expert panel scored 88% of the
edited contours as good opposed to 83% for the clinical contours.¥e total editing time
was 66min.
Conclusions: Multiple-subject ABAS of CT images proved to be a useful novel tool in
rapid delineation of target and normal tissues. Although editing of the autocontours
is inevitable, substantial time reduction was achieved using editing, instead of manual
contouring (180 vs. 66min.).
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2.1 Introduction
¥e large numbers of target and normal tissue structures that requiremanual delineation
in head-and-neck cancer patientsmake contouring tedious and time consuming. In ad-
dition, optimal sparing conditions in the head-and-neck (H&N) IMRT require accurate
delineation of those structures. To ensure consistent delineation of the target volume, a
CT-based atlas of the neck levels I-V and guidelines for critical organs-at-risk (OARs)
were developed and now used [1,2.3,4]However, contouring still suers from intra- and
inter-observer variations [5,6,7].
A promising new tool is autocontouring by atlas-based autosegmentation (ABAS)
of CT-images [9,10,11]. ¥is tool automatically creates the contours for the neck levels
and organs-at-risk in theCT-images of a new patient.Atlas-based autosegmentation has
the potential to lower the contouring burden and thus allow more normal tissues to be
included in inverse treatment planning for high-dose IMRT to fully exploit knowledge
on dose-volume eects. Atlas-based autocontouring also potentially reduces the intra-
observer and inter-observer variability in contouring.
In this study, we have quanti¡ed the accuracy of autocontouring using ABAS and
assess the clinical applicability of this tool. ¥is is to our knowledge the ¡rst paper
describing the validation of ABAS (Elekta) of target tissues (including the neck levels
I-V) and all possible normal tissue structures (including the mastication and swallowing
muscles) in the head-and-neck.We determined the accuracy and time reduction of con-
touring.¥e ¡rst part of the paper assesses the geometrical accuracy ofABAS.TwoABAS
approaches were evaluated (1) selection of the atlas patient with the greatest similarity
metric and (2) combining multiple segmentations of all atlas patients into one segmen-
tation.¥e comparison of amultiple-subject atlas against the use of a single-subject atlas
was quanti¡ed.¥e second part of the study addressed the clinical implementation.¥e
dierences among the clinically used contours, autocontours, and edited autocontours
were quanti¡ed, and the quality of all contours was scored by an expert panel.
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2.2 Material andMethods
Description of ABAS
Atlas-based autosegmentation is the process of performing segmentation on novel data
using the knowledge of a prior segmentation, a dataset that had the structures of interest
already labelled.¥e registration strategy incorporates objects’ shape information in the
atlas to help improve the registration eciency and robustness, while still being able
to account for large intersubject shape dierences. ¥e key component of atlas-based
autosegmentation is a database, (i.e., the so-called atlas), containing image data (e.g. CT
scan data) with delineated contours of the structures (organs) of interest. ¥ese atlas
contoursmust be transferred to the image data of a new patient who undergoing radio-
therapy. ¥e transfer is accomplished by non-rigidly registering the image data of the
atlas to the image data of the new subject. Having obtained the transformation vectors
from the atlas image data to the new subject image data, it is possible to transform the
atlas-contours to the new patient.¥e implementation that was here tested uses for the
non-rigid registration a hierarchical approach (ABAS version 1.1).¥is approach makes
the non-rigid registration procedure ecient and robust, while still being able to regis-
ter large shape dierences that are present between dierent patients. Hierarchical atlas
registration consists of threemajor steps: linear registration; object-driven ‘poly-smooth’
non-linear registration; and shape-constrained dense deformable registration [10,11].
Atlas patients
CT data of 10 H&N cancer patients (4 N0 and 6 N+) was used. An experienced sta
membermanually contoured individual levels I-V (both necks) and twenty OARs (sali-
vary glands, chewing and swallowing muscles, and cord/brainstem) (Table 2.1).
First, the contouring was done by a research fellow and subsequently corrected by
the supervisor. Contouring of the neck levels are according to the international consen-
sus guidelines of Gregoire and Levendag and for the normal tissues according to our
guidelines for delineating OARs [2,3,4,12,13].¥ose contours were used to construct the
atlas and were regarded as a gold standard.¥e total contouring time that was needed to
create the atlas was recorded.¥e contours of levels with invaded muscle inN+ patients
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Table 2.1: Tissues delineated for the atlas.
Tissue n
Submandibular glands 2
Parotid glands 2
Mastication muscles 5×2
Swallowing muscles 5
Spinal cord 1
Neck levels 5×2
were not used for autosegmentation, because in our guideline the anatomical border of
those levels is dierently de¡ned as for levels with a non-invaded muscle. Apart from
the levels with invaded muscle, all other contours ofN+ patients were used by the ABAS
tool.
Atlas Selection
In theory, atlas-based autosegmentation requires just one set of images from a patient as
the atlas. In practice, however, the dierence in the anatomy of patientsmerits the use of
various atlas patients. In this paper, we evaluated two dierent atlas selection strategies
to determine the best approach (¡gure 2.1).
¥e ¡rst approach is a selection of the atlas patient based on the highest similarity
metric between all the atlas patients and the new patient.¥e global mutual information
similarity a¥er the global linear registrationwas used to choose the best atlas.¥e global
Correlation Coecient is only good for linear registration.¥e local correlation coe-
cientwas also evaluated.¥e LocalCorrelationCoecient (LCC) is the usual correlation
coecient computed within a small neighbourhood of each image voxel. ¥e second
approach for an atlas selection strategy is to apply multiple atlas data sets to the CT
data of a new patient, thereby generating multiple sets of autosegmentation sets. For
the fusion of multiple single-atlas autosegmentations, to one multiple-subject autoseg-
mentation, the STAPLE algorithmwas used [14].¥e STAPLE (Simultaneous TruthAnd
Performance LevelEvaluation) algorithmwas introduced byWar¡eld et al.which oers a
more sophisticated strategy formultiple segmentation fusion in that it automatically esti-
mates the segmentation quality of each classi¡er and at the same time derives aweighted
combination of the multiple classi¡ers based on their estimated segmentation quality.
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Figure 2.1: Flow chart input ABAS and strategy evaluation
STAPLE method was applied for each structure separately. For each structure, it takes
as input a collection of segmentation results, one for each atlas. It then simultaneously
computes: (1) a probabilistic estimate of the ‘true’ segmentation and (2) ameasure of the
performance level for each individual atlas result.
Atlas evaluation
For evaluation the mean distance and standard deviation around the mean distance be-
tween the autosegmented structure and the reference structure and the Dice coecient
were calculated. Mean distance measure is the mean distance between corresponding
points in the surfaces of A, B. ¥e surfaces are represented by triangular meshes con-
sisting of sets of node points (triangle vertices), and edges (triangle sides) between the
node points. Since the surfaces have generally dierent numbers of nodes, the distances
d(A, B) are taken from the nodes on one surface A to the nearest node on the other
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structure B.¥e mean distance is de¡ned as:
M(A, B) = 1
N(A) N(A)∑i=0 d(A, B)
where d(A, B) = √(a i − b i)2 is the Euclidean distance from the i-th point on A, a i ,
to b i , the point on B closest to a i , and N(A) is the number of surface mesh nodes on
structure A.¥e standard deviation of the distances is de¡ned as
SD(d(A, B)) =
¿ÁÁÁÀ 1
N(A) − 1 N(A)∑i=0 (d(A, B) −M(d(A, B)))2 .
¥is is ameasure of the degree towhich the distances are spread out over their range.
If the structures are in good agreement, the mean and standard deviation are both small.
¥e Dice coecient is de¡ned as:
Dice = 2 ∣A∩ B∣∣A∣ + ∣B∣
where A and B are the two structures evaluated.¥is formula represents the size of the
union of 2 structures divided by the average size of the two sets. A value of 0 indicates
no overlap; a value of 1 indicates perfect agreement.
¥e leave-one-out cross validation method was used to remove bias, i.e. the patient
for whom autocontours were generated was temporarily removed from the atlas. Levels
with an invaded muscle were excluded from the geometrical validation, because the
border of these levels dier by de¡nition from the levels without invaded muscle. Levels
with invadedmusclewere evaluated in the clinical validation ofABAS (see next section).
Clinical Validation of ABAS
First, for 12 N0 and N+ patients who had undergone intensity modulated radiotherapy
by 10 experienced clinicians and residents, the clinically applied contours (neck levels
and salivary glands)were evaluated by an expert panel and comparedwith the published
atlases [2,3,4,12,13] using the following scores: 0=poor, 1=moderate, 2=good (¡gure 2.2).
¥en, autocontours were generated for those patients by using the multiple-subject
ABAS tool.¥e accuracy of autocontours relative to the published atlaswas evaluated by
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Figure 2.2: Flow chart clinical validation
the expert panel. For the autocontours, the following scoring system was used: 0=poor,
1=major deviation, editable, 2=minor deviation, editable, 3=perfect. Generally , the ex-
pert panel scored it as “minor deviation, editable” when the structures need to be edited
on maximum 3 CT-slices, otherwise it was scored as major deviation, editable. Finally,
for each patient those autocontours were oered to 2 of a group of 5 experienced ob-
servers to edit, if needed, and the editing timeswere recorded. Editing the contourswere
done in Focal version 4.3.3 (Elekta).¥ose edited autocontours were also scored by the
expert panel.¥e Dice coecients and mean distances were calculated to quantify the
dierences among the clinical contours, autocontours, and edited autocontours of the
observers (¡gure 2.2). In addition, other contours, i.e. mastication muscles, swallowing
muscles, and cord-brainstem were autocontoured and edited and editing time was also
recorded.
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2.3 Results
Geometrical validation of ABAS
Time to autocontour all the structures by ABAS was approximately 7 minutes/patient.
¥e initial contouring time for the 30 structures delineated (Table 2.1) was on average
180 minutes per patient. Figure 2.3 shows an example of an autosegmentation of a neck
level, mastication and swallowing muscles using a single-subject and amultiple-subject
atlas.
In this example, the multiple-subject atlas contours were in better agreement with
the reference contours than the selected single-subject atlas contours. ¥e comparison
for all patients and structures was summarized in ¡gure 2.4.
¥is ¡gure shows theDice coecients and mean distances for the single-subject and
multiple-subject approaches.¥e multiple-subject atlasmethod consistently performed
superior to the selected single-subject atlas.¥ose resultswere in agreementwith the fact
that the tested similaritymetrics did not ormoderately correlatewith the accuracy of the
autosegmentation (median R2 of 0.2, range 0.1–0.6). Excluding the levels with invaded
muscle, no signi¡cant dierences were observed in the autosegmentation accuracy for
N0 and N+ patients.
Figure 2.3: Examples of single-subject autosegmentations (white), multiple-subject autosegmentations
(black) togetherwith the reference contours (golden standard) (grey). Left: level II, Right: Swallowing mus-
cle.
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Figure 2.4: Comparing mean distance and Dice coe?cient for the single-subject and multiple-subject
approach. Both metrics quantify the agreement between autocontours and the gold standard. The error
bar equals the standard error and the asterisk denoteswhether the di>erence for a subgroup of structures
is signiBcant at the 0.01 level (paired t-test). Overall, the multiple-subject method performed better (p <
0.001; paired t-test).
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Table 2.2: Dice coe?cient and mean distance for multiple-subject autocontours vs. reference (golden
standard) contours.
Variable Neck levels Parotid
glands
Submandibular
glands
Chewing
muscles
Swallowing
muscles
Spinal cord -
brainstem
Dice coefficient 0.67 0.79 0.70 0.71 0.50 0.78
Mean distance * (mm) 3.4 ± 3.1 2.5 ± 2.8 1.9 ± 1.4 1.6 ± 1.4 2.0 ± 1.9 2.3 ± 1.4
* Mean ± standard deviation.
Figure 2.5: Autocontouring of organs-at-risk (mastication muscles, parotid gland) (left) vs. reference con-
tours (golden standard)(right).
For all patients, the meanDice coecient and mean distances (mm) of the multiple-
subjectmethod were listed in Table 2.2.
Other results of the multiple-subject autosegmentations are shown in ¡gures 2.5, 2.6
and 2.7.
In ¡gure 2.5, an example of the application of auto-ABAS for the contouring ofOARs
(massetermuscles, pterygoid muscles, temporalismuscles and parotid glands) is shown.
Figure 2.6 shows a coronal view of the autocontours and reference contours of levels II
to IV. Figure 2.7 shows the autosegmentation of levels vs. observer contouring. Figure 2.8
shows an autosegmentation example for a neck level with invaded muscle (reference
contour le¥, and multiple-subject autocontour right).
¥emusclewas not included in the autocontour, because the algorithm used the level
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Figure 2.6: Coronal view of autocontours of neck levels (left) vs. reference contours (golden standard)
(right).
of N0 atlas patients to autosegment the involved level of the N+ patient. At the medial
site, some vessels were not encompassed. Both issues can be quickly ¡xed by editing the
autocontour.
Clinical validation
¥emean editing time for neck levels, parotid glands, submandibular glands,mastication
muscles, swallowingmuscles, and cord-brainstemwas 31, 7, 6, 14, 7, and 1min respectively.
¥eDice coecients and themean distance of the clinical contours vs. the autocontours,
autocontours vs. edited autocontours, and the observer 1 vs. observer 2, were listed in
Table 2.3.
Most variation was found for the levels and in particular for the clinical contours
of the levels and the autocontours of the levels. All autocontours (100%) were scored as
“minor deviations/editable” or better by the expert panel.¥e expert panel scored 88%
of the edited contours as good, where 83% of the clinically used contours were scored as
good.¥e automatically generated contours still need to be edited, but the editing time
ismuch less than the time needed formanual delineation from scratch.
Figure 2.7: Autocontouring of levels (white contour) vs. observer contouring (black and grey contours).
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Figure 2.8: Autosegmentation example for a neck level with invaded muscle (reference contour left and
multiple-subject autocontour in right). The musclewas not included in the autocontour, because the algo-
rithm used the level ofN0 atlas patients to autosegment the involved level of theN+ patient.At the medial
site, some vessels were not encompassed. Both issues can be quickly Bxed by editing the autocontour.
Table 2.3: Dice coe?cient and mean distance and SD around the mean distance of di>erent structures
comparing clinical contours, autocontours (AC) and edited autocontours (e-AC). e-AC1 denotes the edited
autocontour of observer 1 and e-AC2 denotes the edited autocontour of observer 2.
Variable Clinical vs. AC Clinical vs. e-AC AC vs. e-AC e-AC1 vs. e-AC2
Dice coe?cient
Neck levels 0.73 0.79 0.83 0.81
Parotid glands 0.80 0.81 0.91 0.89
Submandibular glands 0.72 0.77 0.83 0.86
Mean distance ± SD (mm)
Neck levels 3.2 ± 3.6 2.2 ± 2.8 1.5 ± 2.8 1.8 ± 2.5
Parotid glands 2.3 ± 3.8 2.1 ± 3.0 0.8 ± 1.2 1.1 ± 1.3
Submandibular glands 1.6 ± 1.4 1.2 ± 1.2 1.4 ± 1.8 1.0 ± 1.1
Abbreviations: AC = autocontours; e-AC = edited autocontours; e-AC1 = e-AC of observer 1; e-AC2 = e-AC of observer 2; SD =
standard deviation.
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2.4 Discussion
¥is study described the development, validation and use of the ABAS tool. As seen in
¡gure 2.4 comparisonwith the reference delineation clearly shows the advantage of using
amultiple-subject atlas for segmentation.¥emultiple-subject atlasDice coecients and
mean distances are more satisfactory than thosewith the single-subject atlas.As demon-
strated by ¡gures 2.3–2.6, the organs-at-risk, parotid glands and masticationmuscles are
accurately segmented. From ¡gure 2.6, resemblance is apparent, but the autocontours
still required editing to be used in the treatment planning process.¥e Dice coecients
between the dierent structures are listed inTable 2.3. From these results around 80–90%
agreement between the autocontours and the edited autocontours was found, similar or
slightly better than other published data [15,16,17].Although our data showed a consider-
able inter-patient variability in intravenous contrast uptake, head pose, dental artifacts,
and use of a tongue depressor, all the autocontours were scored as “minor deviations,
editable” or better by the expert panel, a promising result.¥e expert panel scored 88%
of the edited contours as good, where 83% of the clinically used contours were scored as
good. From these data we can state that the edited contours (88% good) were closer to
the published atlas than the ones used in clinic (83% good); the former might make the
delineations for radiotherapy plans for cancer patientsmore accurate. Chao et al. used a
computer-assisted target volumedelineation system and reference templates.¥ey found
that the variation was signi¡cantly reduced but not necessarily the accuracy, which was
beyond the scope of their study [16].It should be remembered that the border in N+
patients with invaded muscle in the present group was de¡ned dierently than those
without invaded muscle.¥erefore, the invaded muscle has to be manually added to the
autocontour of the level [13].
Castadot et al. [15] compared 12 voxel-based deformable registration strategies in
adaptive radiation therapy for the treatment of head-and-neck tumors.His dataset con-
tained 5 patients. ¥ey concluded that level-set Demon’s algorithm (voxel-intensity-
based registration) implemented in multi-resolution is a good strategy for head-and-
neck adaptive radiation therapy as it is the best compromise in terms of median and
inter-quartile range for both the Dice similarity index and correlation coecient. Sims
et al. tried to establish the accuracy of ABAS, such that a priori information was used
to delineate a limited set of organs of interest (brainstem, parotid glands and mandible).
¥e Dice coecients for all OARs were 0.68 ± 0.25 for a ¡rst center and 0.82 ± 0.13 for
a second center. Systematic oversegmentation of the parotids and undersegmentation
of the brainstem occurred that required careful review and editing in most cases [18].
¥ey concluded that the autocontours and the substantial time reduction in contouring
time proved that atlas-based autosegmentation would be a useful novel tool in the rapid
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delineation of neck levels and the limited number of organs-at-risk evaluated. Wang
et al. mapped contours from the planning CT onto daily CT or four-dimensional CT
images using an image intensity-based deformable registration algorithm.Here also only
a limited set of contourswas evaluated (CTV, parotid glands and brain stem).¥e volume
overlap index (A∩B/(A+B)/2)) andmean absolute surface-to-surface distancewas 83%
and 1.3mm, respectively.¥ey concluded that a ¡nal review by physicians is highly rec-
ommended [19]. Commowick et al. presented amethod for creating an anatomical atlas
of the head-and-neck region from a database of 45 manually delineated CT images [9].
¥ey constructed a mean CT image set with atlas contours from a database of patients
beforehand.¥e constructed mean atlas is then applied to a new patient.¥e evaluation
of the built atlas has shown good results both qualitatively and quantitatively, although
some important structures were not included in their database. Our study described an
autosegmentation system with all possibly important (normal tissue) structures needed
for treating head-an-neck cancer included. Zhang et al. showed for 7 patients that atlas-
based image segmentation can automatically delineate the organs-at-risk (mandible,
brainstem and parotids only) on daily CT images [17]. Quantitative validations demon-
strated that the methodwas robust.¥eirDice coecientswere slightly lower than ours.
Other studies [20,21] have shown anatomical changes in parotid and submandibu-
lar glands during radiotherapy, as assessed with non-rigid registration. ¥e non-rigid
registration framework of Va´squez Osorio [21] is an eective method to simultane-
ously register anatomical changes of multiple organs with very dierentmagnitudes and
complexity.General shrinkage and deformation of irradiated glands were observed.¥e
spared glands showed few changes.Anatomical changes can be accommodated by repeat
planning (adaptive radiotherapy), however repeat planning requires re-contouring of the
new CT image or cone beam CT data set, which is tedious and time consuming. In the
future, the ABAS tool might be used to ease adaptive radiotherapy.
2.5 Conclusions
Despite the large inter-patient variability in the study population, neck levels and OARs
could be accurately contoured, using the ABAS tool.¥e multi-subject atlas performed
better than the best single-subject atlas. Although editing of the autocontours is in-
evitable (66min for 30 structures), substantial time reductionwas achieved by editing in-
stead of manually contouring.¥erefore, the new algorithm for autosegmentation could
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substantially reduce the clinical workload spent on organ delineation.¥is is evenmore
relevant, because the edited contourswere scored as having similar or better quality than
the clinically used contours.
chapter 3
Does atlas-based autosegmentation of neck
levels require subsequent manual contour
editing to avoid risk of severe target
underdosage? A dosimetric analysis
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Abstract
Background and Purpose: To investigate the dosimetric impact of not editing autocon-
tours of the elective neck and organs-at-risk (OAR), generated with atlas-based autoseg-
mentation (ABAS) (Elekta so¥ware) for head-and-neck cancer patients.
Materials andMethods: For nine patients ABAS autocontours and autocontours edited
by two observers were available. Based on the non-edited autocontours clinically ac-
ceptable IMRT plans were constructed (designated ‘ABAS plans’).¥ese plans were then
evaluated for the two edited structure sets, by quantifying the percentage of the neck-
PTV receivingmore than 95%of the prescribed dose (V95%) and the near-minimumdose
(D99%) in the neck PTV.Dice coecients andmean contour distanceswere calculated to
quantify the similarity ofABAS autocontourswith the structure sets edited by observer 1
and observer 2. To study the dosimetric importance of editingOAR autocontours a new
IMRT planwas generated for each patient-observer combination, based on the observer’s
edited CTV and the non-edited salivary gland autocontours. For each planmean doses
for the non-edited glands were compared with doses for the same glands edited by the
observer.
Results: For both observers, edited neck CTVs were larger than ABAS autocontours
(p ≤ 0.04), by a mean of 8.7%.When evaluating ABAS plans on the PTVs of the edited
structure sets, V95% reduced by 7.2% ± 5.4% (1 SD) (p < 0.03). ¥e mean reduction in
D99% was 14.2 Gy (range 1–54 Gy). Even for Dice coecients >0.8 and mean contour
distances <1 mm, reductions in D99% up to 11 Gy were observed. For treatment plans
based on observer PTVs and non-edited autocontoured salivary glands, the mean doses
in the edited glands diered by only −0.6 Gy ± 1.0 Gy (p = 0.06).
Conclusions: Editing of autocontoured neck CTVs generated by ABAS is required to
avoid large underdosages in target volumes. O¥en used similarity measures for evalu-
ation of autocontouring algorithms, such as Dice coecients, do not predict well for
expected PTV underdose. Editing of salivary glands is less important as mean doses
achieved for non-edited glands predict well for edited structures.
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3.1 Introduction
Modern intensity modulated radiotherapy (IMRT) treatment planning systems, espe-
cially thosewith biologically based IMRT optimisation, allow users to generate treatment
plans with tight constraints on many organs-at-risk (OARs), while maintaining good
target coverage [22]. A basic prerequisite for IMRT planning is that all OARs for which
constraints are applied needs to be contoured. In addition, due to steep dose gradients
outside the planning target volume (PTV), the accuracy of delineation is becoming of
greater importance. For head-and-neck cancer patientsmanual contouring of the clinical
target volume (CTV), consisting of neck levels to be treated electively, and relevantOARs
typically takes 3 h in our clinic [5].O¥en, the delineations are sensitive to inter-observer
variations. To reduce these inter-observer variations, guidelines for delineation of all
neck levels and OARs have been developed and are currently used in clinical routine
[1,2,3,12,13]. To reduce the time needed for delineation, there is a growing interest in
the use of autocontouring so¥ware. Huykens et al. [23] validated the use of an autoseg-
mentation tool for prostate cancer patients based on CT datasets. ¥e accuracy of the
automatically contoured prostatewas scored as ‘good’, indicating that onlyminormanual
adjustments were needed. For the autocontoured bladder they reported a score between
‘excellent’ and ‘good’. Isambert et al. [24] concluded that an atlas-based autosegmentation
tool was robust and reliable for automatic delineation of large structures in the brain;
however, manual contouringwas still needed for smaller structures.A clinical validation
study on atlas-based autosegmentation for head-and-neck cancer patients was recently
published by Teguh et al. [25].¥ey showed that geometric dierences between autocon-
tours generated with ABAS (Elekta so¥ware) and corresponding edited contours were
relatively small. Dice coecients of 0.8 for the CTV neck levels and 0.9 for the salivary
glands, and mean contour distances of 1.5 mm and 1.1 mm, respectively, were reported.
¥is study also showed that by editing autocontours, the time needed for delineation
compared tomanual contouringwas signi¡cantly reduced from 180 to 66minon average.
When geometric dierences between autocontours and manually edited autocon-
tours are limited, like in the study of Teguh et al. [25], it is questionable whether the
impact of adjusting the autocontours on the ¡nal dose distribution is clinically relevant.
In the PTV some of the dose dierencesmight be diminished by the application ofCTV-
to-PTVmargins to account for set-up accuracy and by the unavoidable non-conformity
of the dose distribution.¥e primary aim of this study is to investigate dosimetric impli-
cations of not editing autocontoured neck levels andOARs derivedwithABAS for head-
and-neck cancer patients. ¥e quality of autocontouring algorithms is o¥en evaluated
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withDice coecients andmean contour distances between edited and non-edited struc-
ture sets.¥e secondary goal of this paper is to investigate whether observed favourable
Dice coecients ormean contour distances do indeed predict for low PTV underdosage.
3.2 Materials andMethods
ABAS and required input
ABAS is a program that segments organs in a CT dataset of a new patient by using one
atlas patient or multiple atlas patients. An atlas patient consists of a CT scan with pre-
de¡ned organs of interest, both target volumes and OARs. A detailed description of the
method has been published by Han et al. [26]. First, non-rigid registration is used to
transform the CT scan of an atlas patient to the CT scan of the new patient. Speci¡c
models for e.g., head-and-neck, prostate and brain are available in the so¥ware, tak-
ing structure-speci¡c information, like elasticity, into account.¥en, using the obtained
transformation, autocontours are generated bymapping the atlas contours to theCT scan
of the new patient. In theory, ABAS just requires one atlas patient to contour a new sub-
ject.However, due to dierences in patients’ anatomies, the accuracy of ABAS improves
when amultiple-subject segmentation approach is used [26].With thismethod, a set of
autocontours is generated for a new patient, based onmultiple atlas patients. To combine
the dierent structure sets to one, the STAPLE algorithm is used [14].
For this study, atlases of 10 randomly chosen head-and-neck cancer patients, with
tumors in the nasopharynx, oropharynx or base of the tongue were used. Four of these
patients were neck-node negative, the others had one or more positive neck nodes. For
each patient neck levels I -Vwere manually delineated on both sides of the neck accord-
ing to international consensus guidelines [1,12,13]. In addition, 20OARswere contoured:
both parotid and submandibular glands, ¡ve swallowing muscles, six chewing muscles,
four adjacent structures (coronoid process, condylar process) and the spinal cord. ¥e
delineations of the neck levels andOARs were checked and approved by an expert panel
of physicians before being used as atlas.
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Table 3.1: Characteristics of patients used in our study
Patient Tumor type TNM Treated neck
levels
Dose interval Followed by
1 Squamous cell Ca. right cheek pT2N0M0 II-IV ri 60 Gy PORT* -
2 Hypopharynx Ca. T2N0M0 II-IV ri+le 46 Gy 24 Gy on primary tumor
3 Nasopharynx/cavum nasi Ca. T2N2M0 RPS**, Ib-V ri+le 70 Gy -
4 Sinus piriformis Ca. T2N0M0 II-IV ri+le 46 Gy 24 Gy on primary tumor
5 Tongue Ca. T2N0M0 Ib-IV ri 46 Gy Brachy therapy boost
6 Supra Glotic Larynx Ca. T3N0M0 II-IV ri+le 46 Gy 24 Gy on primary tumor
7 Glotic Larynx Ca. T2N0M0 II-IV ri+le SIB *** -
8 Oropharynx Ca. T1N2bM0 RPS, Ib-IV ri 46 Gy BT + ND ****
9 Base of tongue Ca. T3N1M0 Ib-IV ri, Ib-V le 46 Gy BT + ND ****
* PORT: post-operative RT
** RPS: retropharyngeal space
*** SIB: Simultaneous integrated boost, 30×2.3 Gy primary tumor, 30×1.7 Gy neck levels
**** BT + ND: Brachytherapy boost + neck dissection
Dosimetric impact of editing autocontours on PTV coverage
In Table 3.1 characteristics of the nine patients used in this study are given. For each of
the patients a physicianmanually contoured the primary tumor.
In addition, based on the 10 atlas patients, showing no overlapwith our current study
patients, autocontours for the elective neck levels and theOARswere generated using the
head-and-neck algorithm in ABAS. Subsequently, two well-trained physicians (OBS1,
OBS2) edited the ABAS contours for the elective neck CTVs and salivary glands to a
clinically acceptable structure set. For each patient, the primary tumor and the elective
neck levels were expanded by 5 mm to produce the PTV in each of the three structure
sets (PTVABAS, PTVOBS1, and PTVOBS2).
For each of the nine patients a clinically acceptable IMRT plan, designated ABAS
plan, was constructed based on the ABAS autocontours usingMonaco (Elekta so¥ware,
version 1.0). For these ABAS plans, the dose coverage of the PTVOBS1 and PTVOBS2 was
evaluated by quantifying the percentage of the volume receiving more than 95% of the
prescribed dose (V95%), and the minimum dose delivered to 99% of the PTVOBS1,2, i.e.,
the near- minimum dose (D99%). To analyse eects of small geometrical dierences, this
analysis was repeated for PTVs that were contracted by 1, 2 and 3mm, respectively.
To quantify the similarity between CTVs derived with ABAS and corresponding
editedCTVs by eitherOBS1 orOBS2,Dice coecients andmean contour distanceswere
calculated.¥e Dice coecient is ameasure of the overlap of two structures A, B [27]:
Dice = 2 ∣A∩ B∣∣A∣ + ∣B∣
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where ∣A∣, ∣B∣ represent the volumes of the structures and ∣A ∩ B∣ is the volume of in-
tersection.¥eDice coecient can range from 0 (no overlap) to 1 (perfect overlap).¥e
mean contour distance is de¡ned as:
M(A, B) = 1
N(A) N(A)∑i=0 d(A i , B i)
where d(A i , B i) is the shortest distance from point i on surface A to the closest point
on surface B, and N(A) is the total number of surface points on contour A. In case of
perfect overlap themean contour distance = 0.A non-parametric Spearman’s correlation
test was used to assess the correlation between dierences in V95%, D99% and either the
Dice coecients or the mean contour distances.
Dosimetric impact of editing OAR contours on dose in salivary glands
To study the dosimetric impact of editing autocontoured salivary glands, 18 other IMRT
planswere made based on either PTVOBS1 or PTVOBS2 and the non-edited autocontours
for the salivary glands. For each plan the mean doses in the (non-edited) autocontoured
glands were compared with the mean doses in the parotid and submandibular glands
edited by eitherOBS1 orOBS2.A non-parametricWilcoxon signed rank testwas used to
determine whether the observed dierences inmean doses were statistically signi¡cant.
3.3 Results
Dosimetric impact of editing autocontours on PTV coverage
InTable 3.2 the geometric overlap between the autocontouredCTVs and the editedCTVs,
as quanti¡ed by the Dice coecient and the mean contour distance are summarized.
Betweenbothobservers no statistically signi¡cantdierenceswereobserved (p>0.57).
However, the edited neck CTVswere larger than the corresponding autocontoured neck
CTVs,withmean dierences of 9.9% and 7.5% forOBS1 andOBS2, respectively. In a non-
parametricWilcoxon signed rank test, these volume increases were statistically signi¡-
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Table 3.2: Summary of the geometric overlap between the autocontoured CTVs and the edited CTVs for
the 9 study patients. ∆Volume quantiBes the volume increase of the edited CTVs compared to the corre-
sponding ABAS contours. For each of the parameters no statistically signiBcant di>erences are observed
between observer 1 and 2.
Observer 1 Observer 2 Wilcoxon signed rank test
mean (range) mean (range) Observer 1 vs Observer 2
Dice coefficient 0.82 (0.69–0.95) 0.81 (0.64–0.89) p = 0.57
Mean distance (mm) 1.7 (0.6–4.9) 1.7 (0.8–3.9) p = 0.77
∆Volume CTV(%) 9.9 (0.7–32.8) 7.5 (−1.9–17.5) p = 0.77
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Figure 3.1: Reduction in PTV volume receiving at least 95% of the prescribed dose (A) and in the near-
minimum dose in this volume (B) when evaluating the ABAS plan on the PTV of OBS 1 (△) and OBS2 (●)
respectively.
cant (p = 0.01 and p = 0.02, respectively).During editing, the observersmainly enlarged
the CTVs at the lateral borders. For the ABAS plans the mean V95% of PTVABAS was
97.1% ± 1.5% (1 SD).Deviations from the prescription that at least 99% of the PTV should
receive 95% of the prescribed dose were mainly observed in air cavities inside the PTV
and/or in super¡cial parts of the PTV close to the body surface (i.e., in the build-up
region).When evaluating the ABAS plans for PTVOBS1 and PTVOBS2, V95% reduced by
6.5% ± 4.4% and by 7.8% ± 6.5% respectively (see Figure 3.1A).Again, for both observers,
this reductionwas statistically signi¡cant (p = 0.01 and p = 0.02, respectively).¥e mean
reduction inD99% was 14.1Gy (range 1–36Gy) for PTVOBS1 and 14.4Gy (range 2–54Gy)
for PTVOBS2 (see Figure 3.1B).
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Figure 3.2: Example of a patient (patient 9 in Table 3.1) showing a good geometric similarity between the
autocontoured neck CTV generated with ABAS (Blled grey area) and the edited CTV contours of OBS1 and
OBS2 (grey lines).While the two PTVs based on the edited autocontoured CTVs were not fully covered by
the ABAS plan, no underdosages were observed after contracting these volumes by 2 mm.
¥e large deviations for patient 1 are caused by the fact that observer 2 considered
partial inclusion of neck level IV in the CTV essential, thereby enlarging the volume at
the caudal side by 3 cm compared to the autocontoured neck CTV.
Only for patient 6 the dose coverage for PTVOBS1, as quanti¡ed by V95% and D99%,
was similar to the one for PTVABAS without contracting the PTV contour (as described
inmaterials and methods). In six of the eighteen cases, contracting PTVOBS1 ,2 by 2mm
resulted in a similar or better dose coverage compared to PTVABAS (see Figure 3.2 for an
example).
But in eight cases contracting of PTVOBS1 ,2 by 3 mm was still not sucient to get a
similar dose coverage. For this subgroup, the mean dierences in V95% in the contracted
PTV were still 3.3% (range: 1–19%).
In Figure 3.3, the observed reductions in V95% and D99% are plotted for all study
patients versus theDice coecients between theABAS autocontours and the editedCTV
contours by OBS1 and OBS2.
A statistically signi¡cant correlationwas found in both cases (p < 0.001 and p = 0.003
respectively). ¥e correlation between the reductions in both V95% and D99% and the
mean contour distances (not shown) was not statistically signi¡cant (p = 0.06 and 0.57,
respectively). A large spread around the linear correlations is observed, implying that
relatively highDice coecients (>0.8) or small mean contour distances (<1mm) can still
be accompanied by large PTV underdosages.
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Figure 3.3: Correlation between the Dice coe?cient and the reduction in PTV receiving at least 95% of
the prescribed dose (A) and the reduction in near-minimum dose in this volume (B) when evaluating the
ABAS plan on the PTV ofOBS 1 (△) andOBS2 (∎) respectively. The plotted trend lines are tested statistically
signiBcant in a Spearman’s correlation test.
Dosimetric impact of editing OAR contours on dose in salivary glands
When evaluating IMRT plans based on either PTVOBS1 or PTVOBS2 and non-edited
ABAS salivary glands, the mean doses in the edited parotid glands diered by −0.8 Gy
± 1.1Gy (1SD) and in the edited submandibular glands by −0.2Gy ± 0.7Gy (1SD).¥ese
relatively small dierenceswerenot statistically signi¡cant (p= 0.12 forOBS1 and p= 0.29
for OBS2).
3.4 Discussion
In this study we have demonstrated that the use of ABAS autocontours generally results
in large underdosages in the target volumes.¥e fact that in eight of the eighteen cases
contracting the PTVs by 3mmdid not yet result in adequate dose coverage indicates that
local dierences are o¥en quite large. Editing of the neck CTVs resulted in seventeen of
the eighteen cases in a volume increase of the CTV, indicating either that observers tend
to enlarge a neck CTV rather than diminish it, or that the output of ABAS is too small
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for the majority of cases.¥e main dierences are observed at the lateral borders of level
II, III and IV. According to the atlas guidelines [1,12,13] this lateral border should be at
the exact transition of the fat space and the sterno-cleido mastoid muscle, but in this
study we observed that physicians tend to include up to 3mm of thismuscle in the CTV
as well. In addition, some adjustments in autocontours, like for patient 1, were driven
by the physician’s judgement of patient speci¡c information. To improve the accuracy
of the output of ABAS, a future revision of the applied atlases might be considered.
However, before changing any atlas we plan to investigate a larger patient cohort ¡rst
because intersubject variations are large in head-and-neck cancer patients and wrongly
adapted atlases could cause systematic errors.Moreover, adaptation of the atlases should
preferentially be based on adaptation of the consensus guidelines.
In a recent study, Tsuji et al. [28] evaluated the dosimetric impact of autosegmen-
tation for adaptive IMRT for head-and-neck cancer patients. In this study, structures in
themid-treatmentCTwere derived by transformingmanually delineated contours in the
initial planningCT, based on deformable registration between bothCT sets.When using
the autocontoured structures to create an adaptive treatment plan, a signi¡cantly lower
mean dose coverage of the manually delineatedGTV and theCTV in the mid-treatment
CT was observed. A similar result was found in our study, when autocontouring a new
patient based on ten atlas patients. In contrast to the ¡ndings of Tsuji et al., our data
showed a statistically signi¡cant correlation between Dice coecients and target cover-
age. However, in clinical practice, this correlation has a very limited value, since Dice
coecients and mean contour distances cannot be determined before editing the auto-
contours. So, the amount of underdosages of the target cannot be assessed beforehand. In
addition, the scatter in the results shown in Figure 3.3 indicates that bothDice coecients
and mean contour distances have little predictive value regarding the impact on dose
coverage. In some publications the similarity of two volumes is considered good if a
Dice coecient is 0.7 or higher (see e.g., [29]). But for a tumor volume, such a geometric
overlap does not necessarily result in acceptable dose coverage. Even forDice coecients
of 0.8, underdosages in the PTV of up to 11 Gy were observed in this study.
Editing of salivary glands, taking 13 min on average [25], generally leads to small
dierences in themean dose in these organs, indicating that thismight be omitted, espe-
ciallywhen themean dose is expected to bemuch lower or higher than the objective.Also
re-planning, e.g., a¥er anatomical changes during treatment, can generally be performed
usingnon-edited salivary gland contours because it is already known from the initial plan
whether the mean doses are critical. Editing is only essential whenmean doses inOARs
get close to their objectives.
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3.5 Conclusion
Editing of CTV neck contours generated by ABAS is essential to avoid large (local)
underdosages in the target volume.When applying highly conformal IMRT plans with
steep gradients towardOARs and the surrounding tissues, small geometrical dierences
in the CTV volume will o¥en have a large dosimetric impact on the dose coverage of
the target.However, editing salivary glands has only a small impact on the mean dose in
these OARs and might o¥en be avoided. Dice coecients and mean contour distances
are useful to quantify the geometric overlap of dierent structure sets, but are of limited
value to predict dosimetric target coverage and plan quality.
chapter 4
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Abstract
Purpose:To quantify improved salivary gland sparing for head-and-neck cancer patients
using intensity-modulated radiotherapy (IMRT) plans based on integrated computerized
optimization of beam orientations and intensity pro¡les. To assess if optimized nonzero
couch angles also improve VMAT plans.
Methods: Our in-house developed algorithm iCycle was used for automated genera-
tion of multicriterial optimized plans with optimized beam orientations and intensity
pro¡les, and plans with optimized pro¡les for preselected beam arrangements. For 20
patients, ¡ve IMRT plans, based on one ‘wishlist’, were compared: i), ii) seven and nine
beam equiangular coplanar plans (iCycle7equi, iCycle9equi), iii), iv) nine-beam plans with
optimized coplanar and noncoplanar beam orientations (iCyclecopl, iCyclenoncopl) and
v) a nine-beam coplanar plan with optimized gantry angles and one optimized couch
rotation (iCyclecouch).VMAT planswithout andwith this optimized couch rotationwere
evaluated.
Results: iCyclenoncopl resulted in the best salivary gland sparing,while iCyclecouch yielded
similar results for 18 patients. For iCycle7equi, submandibular gland NTCP values were
on average 5% higher. iCycle9equi performed better than iCycle7equi. iCyclecopl showed
further improvement. Application of the optimized couch angle from iCyclecouch also
improved NTCP values in VMAT plans.
Conclusions: iCycle allows objective comparison of competing planning strategies. Inte-
grated optimization of beam pro¡les and angles can signi¡cantly improve normal tissue
sparing, yielding optimal results for iCyclenoncopl.
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4.1 Introduction
Intensity-modulated radiotherapy (IMRT) with computer-optimized beam pro¡les has
become standard care for curative treatments of head-and-neck cancer patients. Until
now, it has been common practice that a dosimetrist selects the applied number of beams
and their orientations in a trial-and-error process.¥is is not straightforward, especially
for complex treatment sites involving many organs-at-risk (OARs). ¥e quality of the
¡nal plan may thus depend on the skills and experience of the planner. Alternatively, a
template solution is o¥en used per target site to derive clinical IMRT plans.
For head-and-neck cancer patients, published data on the impact of (computer)
optimized and patient-individualized beam arrangements on the quality of treatment
plans are limited. In most comparative studies for head-and-neck cancer IMRT very
few patients were included and equispaced coplanar beam arrangements were used as
reference. Meedt et al. [30] reported on coplanar beam angle-optimization (BAO) for
one laryngeal-cancer patient. BAO plans with six or seven beams were compared to a
manually de¡ned nine-¡eld plan and a plan with 15 equiangular beams. Target coverage
was improved for both BAO plans, andmean doses inOARswere reduced.Djajaputra et
al. [31] used an extensive search from dierent sets of beams to derive an optimal beam
angle con¡guration. For one head-and-neck cancer patient they showed that the use of
seven or nine noncoplanar beams with optimized angles improved the plan quality over
that of nine equiangular coplanar beams.Wang et al. [32] investigated the eectiveness
of noncoplanar BAO in ten paranasal sinus carcinoma patients. Five beams with opti-
mized beam angles generallyperformedbetter thanplanswithnine equiangular coplanar
beams. Nutting et al. [33] determined the added value of noncoplanar BAO plans over
coplanar BAO plans for 6 parotid gland carcinoma patients. Each plan consisted of 3
or 4 ¡elds. For the noncoplanar plans, the inhomogeneity in the PTV was greater, and a
higher normal brain volume received a dose of at least 54Gy.¥ey reported no signi¡cant
advantage for noncoplanar BAO. A limitation of their study was the small number of
beams used; most studies in the literature suggest that at least 7 beams are required to
achieve an optimal IMRT plan.
In previous publications on BAO our groupmainly investigated in-house developed
algorithms for beam angle,weight and shape optimization in 3DCRT,with a special focus
on liver SBRT. For IMRT, only a simple segmented approach was investigated [34], or
beam angle and beam pro¡le optimization were performed consecutively [35].¥e latter
approach started with selection of optimal beam angles for 3DCRT, using an in-house
BAO algorithm. Intensity pro¡les for these angles were then optimized with a commer-
cial treatment planning system (TPS). Itwas demonstrated thatwith anoncoplanar beam
arrangement OARs could be better spared than with coplanar beams only. BAO is now
Materials andMethods | 41
ch
ap
te
r4
clinically applied for 3DCRT plan generation in liver SBRT [36].Recently,we developed a
multicriterial plan optimization algorithm for integrated beam angle and beam intensity
optimization, called iCycle [8,37,38] Outputs of iCycle are Pareto-optimal IMRT plans
with optimized beam setups.With Pareto-optimal we mean that none of the objectives
in the applied ‘wishlist’ (see materials and methods section) can be improved any fur-
ther without deteriorating one or more constraints or higher prioritized objectives. For
preselected ¡xed beam arrangements, iCycle can also be used to optimize beam pro¡les
only. In this study, iCycle was used to systematically compare IMRT plans for various
beam angle selection strategies in 20 randomly selected head-and-neck cancer patients.
Each plan aimed at maximum salivary gland sparing while obtaining the prescribed
high tumor coverage. Due to the proximity of several OARs to the PTV, we expected
that the use of noncoplanar beam arrangements could be bene¡cial, like for liver SBRT
patients [35].Variations in the procedure for beam angle selection resulted in seven- and
nine-beam equiangular coplanar plans, coplanar plans with optimized gantry angles,
fully noncoplanar plans with optimized couch and gantry angles, and coplanar plans
with optimized gantry angles for various non-zero couch angles. To assess the eect
of these nonzero couch angles in VMAT plans, we used a commercial TPS to generate
two dierent VMAT plans for 2 patients. For the ¡rst VMAT plan we used the regular
0° couch angle; for the second plan the couch angle corresponding to the nine-beam
coplanar plan generated with iCycle, showing the lowest mean NTCP in the salivary
glands, was used.
4.2 Materials andMethods
Study patients and clinical treatment plans
Twenty recently treated head-and-neck cancer patients with various tumor sites were
randomly selected from our clinical database (Table 4.1).
For treatment, IMRT plans were made using Monaco (version 2.04, Elekta). ¥e
intentionwas to draw up the best clinically acceptable treatment plan for each patient on
the basis of target coverage, sparing of organs-at-risk, and number of beams.¥e main
focus was put on minimization of the mean dose in the salivary glands (both parotids
and submandibular glands)with the intend tomaintain salivary ¤ow asmuch as possible
[39,40], while assuring that at least 98.5% of the PTV was treated with at least 95% of the
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Table 4.1: Characteristics of patients used in this study.
Patient Tumor type TNM Dose interval Followed by
1 PalatumMolle Ca. T2N2cM0 46 Gy Cyberknife boost
2 Tonsillar fossa Ca. T2N0M0 46 Gy Cyberknife boost
3 Tonsillar fossa Ca. T3N0M0 46 Gy Cyberknife boost
4 Tonsillar fossa Ca. T2N0M0 46 Gy Cyberknife boost
5 Tonsillar fossa Ca. T2N0M0 46 Gy Cyberknife boost
6 Tonsillar fossa Ca. T2N0M0 46 Gy Brachytherapy boost
7 Tonsillar fossa Ca. T1N2aM0 46 Gy Brachytherapy boost
8 Tonsillar fossa Ca. TxN0M0 46 Gy Brachytherapy boost
9 Tonsillar fossa Ca. T2N0M0 46 Gy Brachytherapy boost
10 Oropharynx Ca. T3N0M0 46 Gy Cyberknife boost
11 Oropharynx Ca. T2N0M0 46 Gy Cyberknife boost
12 Oropharynx Ca. T1N0M0 46 Gy Brachytherapy boost
13 Oropharynx Ca. T2N0M0 46 Gy Brachytherapy boost
14 Base of tongue Ca. T4aN1M0 46 Gy Cyberknife boost
15 Base of tongue Ca. T1N1M0 46 Gy Cyberknife boost
16 Base of tongue Ca. cT1N2bM0 46 Gy Brachytherapy boost
17 Cheek Ca. T4aN0M0 46 Gy 24 Gy primary tumor
18 Floor of mouth Ca. pT4aN0M0 66 Gy PORT
19 Parotid Ca. pT2N0M0 66 Gy PORT
20 Nasopharynx Ca. T1N2M0 70 Gy Brachytherapy boost
PORT: post-operative RT
prescribed dose and keeping the maximum dose in critical serial organs below a ¡xed
threshold value. (e.g., 50 Gy for the spinal cord). In most cases this resulted in a seven-
beam IMRT plan.
iCycle: Integrated beam angle and proBle optimization
iCycle is a novel in-house developed algorithm for integrated beam angle and beam pro-
¡le optimization [8,37,38].¥e algorithm is described in detail in [8].Herewewill brie¤y
summarize the main characteristics. Core of iCycle is the 2-phase ε-constraint (2pεc)
algorithm for generating optimal IMRT plans for preselected (¡xed) beam arrangements.
¥is algorithm has amulticriterial optimization approach that generates a single Pareto-
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Table 4.2: Applied wishlist for all study patients. SMG = submandibular gland
Constraints
Volume Type Limit
PTV maximum 107% of prescribed dose
Spinal cord maximum 38 Gy (*48 Gy)
UnspeciBed tissue maximum 107% of prescribed dose
*48 Gy for patients 18–20.
Objectives
Priority Volume Type Goal Su?cient Parameters
1 PTV LTCP 1 0.5 α = 0.8
2 Parotid/SMG mean 39 Gy
3 Parotid/SMG mean 20 Gy
4 Parotid/SMG mean 10 Gy
5 Parotid/SMG mean 2 Gy
6 PTV shell 1 cm maximum 35 Gy
7 PTV shell 2 cm maximum 30 Gy
8 PTV shell 3 cm maximum 25 Gy
9 PTV shell 4 cm maximum 20 Gy
10 PTV shell 5 cm maximum 15 Gy
optimal plan for the preselected beam angles. Basis is a user-de¡ned ‘wishlist’ containing
the clinical plan objectives that all have an ascribed priority and hard constraints to be
strictly obeyed during plan generation (see Table 4.2 for an example).
In iCycle, beam pro¡le optimization is integrated in an iterative procedure for se-
lection of optimal beam directions. Starting with zero beams, new beams with optimal
directions are consecutively selected from a list of candidate beams and added to the plan.
For selection of a next beam orientation, ¡rst, all candidate directions not yet selected
are temporarily added to the con¡guration established in the previous iteration, and the
IMRT optimization problem is solved. In the end, the orientation with the best score
is added to the beam con¡guration. For each orientation added this results in one new
Pareto-optimal IMRT plan. Identical wishlists can be used for groups of patients, e.g.,
for all head-and-neck cancer patients with the main focus on sparing of salivary glands,
making plan generation fully automatic and user independent.
¥e 2pεc algorithm consists of two phases. First, all objectives are consecutively
minimized within hard constraints, trying to reach their prede¡ned goal values (but not
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below), startingwith the highest prioritized objective (seeTable 4.2).A¥erminimization,
the objective is turned into a constraint, applying the attained value.¥ismethod ensures
that in the following minimizations of lower prioritized objectives, the attained value of
the just optimized objectivewill at least bemaintained.Another advantage is that for each
patient one can start with the same wishlist with demanding objectives. In the second
phase, objectives that could have been reduced below their de¡ned goal as used in the
¡rst phase are sequentially furtherminimized, again startingwith the highest prioritized
objective. Except for objectives for the target dose, in the second phase all objectives are
minimized to the full extent. Minimization of the target objective is stopped at a user-
de¡ned ‘sucient’ value, accepting small deviations from 100% coverage of the PTVwith
95%of the prescribed dose to leave roomforminimization of lower prioritized objectives.
Apart from the wishlist, the only input that iCycle requires to generate plans is a
prescribednumber of beams, and a listwith candidate beamdirections thatmay be added
to the plan.¥is listmay be restricted for generation of coplanar plans with couch angle
0°, but itmay also contain a large set of orientationswith various couch and gantry angles
that can be delivered without crashes between the gantry and the couch or patient.
Asmentioned above, in the process of generating a planwith the prescribed number
of beams, Pareto-optimal plans will also be generated for smaller beam numbers. ¥e
plan with the highest number of beams has the best plan quality regarding the highest
prioritized objective that isminimized to its full extent (see above).However, dierences
with plans with fewer beams may be small, making a plan with fewer beams attractive
because of reducedQAworkload or treatment time.On the other hand, if the evaluation
of plan quality as a function of beam number shows that more beams than initially
prescribedwould result in a better plan quality, iCycle can easily be instructed to generate
more plans with higher beam numbers.
iCycle plan generation for the study patients
¥e applied wishlist is depicted in Table 4.2. It contains hard constraints on the max-
imum allowed dose in the PTV, spinal cord and unspeci¡ed tissue. For patients 1–17,
the maximum allowed dose in the spinal cord was set to 38 Gy, i.e., lower than our
clinically used constraint, to leave sucient room for optimizing the subsequent boost
plan. ¥e objective with priority 1 was to achieve adequate target coverage. ¥e target
dose was optimized byminimizing the Logarithmic Tumor Control Probability (LTCP)
as described by Alber et al. [41]. A prescription dose and an alpha parameter, aecting
the penalty given to underdosed voxels in the tumor, are inputs to derive the LTCP. On
Materials andMethods | 45
ch
ap
te
r4
the basis of the ¡rst ¡ve study patients, alpha was set at 0.8, which ensured that at least
98.5% of the PTV volume received at least 95% of the prescribed dose for all treatment
plans. Objectives 2–5 aimed at a balanced reduction of the mean dose in each of the
individual salivary glands. Since the PTV objective was higher prioritized, target dose-
coverage never reduced. Finally, to achieve a steep dose fall-o outside the target volume,
maximum dose objectives were de¡ned for a set of shells with 0.3 cm thickness at 1, 2, 3,
4 and 5 cm of the PTV.
For coplanarBAO, beamswere selected from 72 equiangular spaced candidate beams.
For noncoplanar BAO, we added noncoplanar candidate beams with a 10° separation,
resulting in approximately 320 beams in total.¥e coarser separation of the noncoplanar
candidate beams reduced the time required for BAOwithout compromising plan quality.
In this study, we used a maximum noncoplanar beam angle in cranial direction of 45°.
Beams outside this range would never be selected due to the applied maximum dose
objectives outside the PTV (objectives 6–10 in Table 4.2). We also omitted candidate
beams at both sides of the sphere that could result in collisions between the gantry and
the patient or the treatment couch. Consequently, the list of feasible candidate beams
used by iCycle for noncoplanar BAO depends on target site and treatmentmachine.
Using iCycle, the following plans were derived for the patients in this study:
1. a seven-beam coplanar equiangular plan at couch angle 0° (iCycle7equi).
2. a nine-beam coplanar equiangular plan at couch angle 0° (iCycle9equi).
3. a nine-beam coplanar plan with optimized gantry angles at couch angle 0°
(iCyclecopl).
4. a nine-beam noncoplanar plan with optimized gantry and couch angles
(iCyclenoncopl).
5. a nine-beam coplanar plan with optimized gantry angles and an optimal
couch angle (iCyclecouch). ¥is plan was selected from 9 sequentially opti-
mized iCycle plans, generated for ¡xed couch angles at 340°, 345°, 350°, 355°,
5°, 10°, 15°, 20°, or 0° (i.e., iCyclecopl), based on the lowestmeanNTCP for the
salivary glands.
iCyclecouch was investigated because this plan requires one single couch rotation at
the start of treatment only; next, all beams can be delivered without the technicians
having to enter the treatment room in between. In contrast, treatment of fully noncopla-
nar plans is more labor-intensive and time-consuming, as technicians have to enter the
treatment room tomanually execute prescribed couch rotations.
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Impact of couch angle on VMAT plans
For the two study patients who bene¡ted most from using an optimized couch angle for
the coplanar plan (i.e., showing the largest dierence inmean salivary glandNTCPwhen
comparing iCyclecopl and iCyclecouch), we investigated whether VMAT plans could be
improved by using this optimized couch angle, instead of the commonly used zero couch
angle. Single, full-arc VMAT-plans were generated with Monaco for both situations.
Dierences in salivary gland sparing were quanti¡ed.
Comparison of treatment plans
Like in our clinically used plans, plan evaluation was mainly focused on the achieved
salivary gland sparing.We compared mean doses in each of the glands.Moreover, these
mean doses were converted into NTCP values, using published dose-response models
for parotid [39] and submandibular glands [40]. Both NTCP models are based on the
probability ofGrade 4 toxicity (i.e., salivary ¤ow rate <25%of baseline pre-radiotherapy).
A two-sidedWilcoxonmatched-pair signed-rank test [42] was used to compare the dif-
ferent iCycle plans for the patient group.
4.3 Results
Comparison of iCycle plans
With the applied wishlist, at least 98.5% of the PTV received 95% of the prescribed dose
for all plans. For 18 of the 20 patients this applied for even more than 99% of the PTV.
Due to applied hard constraint in the wishlist, observed maximum doses in the spinal
cord remained below 38 Gy for patients 1–16, and below 48 Gy for patients 17–20. For
patient 20, the observed maximum dose for brainstem was 48 Gy, while the maximum
doses in the optical chiasm, optical nerves and eyes were less than 40 Gy. In all other
patients themaximumdoses in the brainstemwere below 38Gy and themaximumdoses
in the optical chiasm, optical nerves and eyes below 25 Gy.
Figure 4.1 comparesmean salivary gland doses for iCyclenoncopl with the correspond-
ing doses in the other iCycle plans.
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Figure 4.1:Mean salivary gland doses for all coplanar techniques compared to iCyclenoncopl .
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Figure 4.2:Di>erences inNTCP values for all plans relatively to iCyclenoncoplan , visualized per salivarygland.
NTCP values of glands that could not be spared, because they were entirely enclosed in the PTV, were
omitted.
Figure 4.2 shows the NTCP dierences between iCyclenoncopl and the other plans.
In Table 4.3, these dierences are summarized.¥e lowestmean salivary gland doses
were observed for iCyclenoncopl. Dierences with iCycle7equi, iCycle9equi, and iCyclecopl
were statistically signi¡cant (p < 0.001).
Compared to iCyclecouch, only the dierences in mean submandibular gland dose
were statistically signi¡cant (p = 0.05). For iCycle7equi, iCycle9equi and iCyclecopl, the
observed increases in mean salivary gland doses compared to iCyclenoncopl also trans-
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Table 4.3: Di>erences between iCyclenoncopl and all other plans in mean salivary gland dose and NTCP,
averaged over the 20 study patients, for both parotid and submandibular glands. For iCyclenoncopl , the
mean parotid and submandibular gland doses were 17.5 Gy (range: 0.8–38.7 Gy) and 24.5 Gy (range: 2.0–
41.0 Gy), respectively.Mean NTCPs were 7% (range: 1–47%) and 30% (range: 10–65%).
iCycle7equi iCycle9equi iCyclecopl iCyclecouch
Parotid glands ∆mean dose*(Gy) 2.5 1.4 0.7 0.1
SD (Gy) 2.2 1.9 1.2 0.7
Range (Gy) −0.2–9.1 −0.6–7.7 −0.8–4.4 −1.2–2.3
p-value* <0.001 <0.001 <0.001 0.203
∆ NTCP*(%) 2.8 1.6 0.7 0.1
SD (%) 3.5 2.7 1.4 0.8
Range (%) −0.2–14.4 −0.7–12.0 −1.1–6.7 −1.5–2.8
p-value* <0.001 <0.001 0.005 0.629
Submandibular glands ∆mean dose*(Gy) 3.1 1.7 1.2 0.6
SD (Gy) 2.6 1.5 2.0 1.7
Range (Gy) −0.5–8.8 0.0–5.3 −1.1–8.6 −1.5–7.9
p-value* <0.001 <0.001 <0.001 0.05
∆ NTCP*(%) 5.0 2.8 1.5 0.5
SD (%) 5.1 2.7 2.0 1.5
Range (%) 0–20.0 0–8.5 0–8.5 −2.0–6.0
p-value* <0.001 <0.001 0.001 0.085
lated in statistically signi¡cant increased NTCPs (Table 4.3). iCycle7equi yielded higher
mean salivary gland doses and NTCPs than each of the nine-beam techniques. BAO for
iCyclecopl resulted in better salivary gland sparing than achieved with iCycle9equi.
¥e observed mean NTCP dierences between dierent planning techniques are
small. However, one should keep in mind that the mean NTCP values for iCyclenoncopl
were 7% for the parotid glands and 30% for the submandibular glands. ¥erefore, in a
relative sense, iCyclenoncopl had a far lower risk for damaging parotid glands than e.g.,
iCycle7equi. Moreover, the gain of applying a more advanced planning technique was
patient dependent (see Table 4.3). For example, the mean dierence in NTCP for the
submandibular glands between iCycle7equi and iCycle9equi was 2.2%;whereas, in patient 5
the use of nine-beams reduced the NTCP for the right submandibular gland from 40%
to 29%. For the parotids, the mean NTCP dierence between iCycle9equi and iCyclecopl
was 0.9%, but in patient 20 the NTCPs reduced from 53% to 47% and 44%, respectively.
Compared to iCyclecopl, use of the optimal couch angle (iCyclecouch) improved the
NTCP for parotid glands by up to 4% and for submandibular glands by up to 3%. For 18
of the 20 patients, NTCPs for iCyclecouch were similar to the values for iCyclenoncopl.
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Table 4.4:Mean doses in salivary glands (Gy) for VMAT plans with a couch angle of 00 and with the opti-
mized couch angle from iCyclecouch. Submandibular glands for patient 18 were omitted in the table since
they were fully included in the PTV.
Patient 4 Patient 18
VMAT 0° VMAT 350° VMAT 0° VMAT 340°
Right parotid 22.7 20.6 13.9 9.2
Left parotid 26.6 24.8 42.5 39.1
Right submandibular gland 44.3 42.7 – –
Left submandibular gland 35.6 35.2 – –
Calculation times for generating iCycle plans
¥e calculation time for the beam angle optimization phase in iCycle scales linearly with
the number of candidate beams. For the multicriterial optimization, the required time
grows to the power of three with the number of beams. Moreover, it depends on the
number of constraints and objectives in the wishlist. For this part, calculation times are
similar for coplanar and noncoplanar iCycle plans.
Using a modern eight-core server, calculation times were typically 3 hours for the
nine-beamcoplanar BAO plans and 12 hours for the noncoplanar plans using a voxel size
of 0.98 x 0.98 x 2.5mm3, identical to the CT resolution. For small structures like optical
nerves, all voxelswere included in the optimization. For larger structures, approximately
5000 voxels were selected based on a Hammersley sequence sampling. For all individual
plans, a calculation gridsize of 5 x 10 mm was used (based on an MLC with 1 cm leaf
width).
Impact of couch optimization on VMAT plans
Patients 4 and 18 had the largest reduction inmean salivary glandNTCPwhen changing
from iCyclecopl to iCyclecouch. For these patients, the optimal couch angle was 340° and
350° respectively.Table 4.4 shows salivary gland doses forVMAT planswith couch angles
0° and 340°/350°. Like observed for iCyclecouch, use of the optimal couch angle improved
the salivary gland sparing for VMAT plans as well.
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4.4 Discussion
To our knowledge, this is the ¡rst systematic study on the impact of beam angles on sali-
vary gland sparing in head-and-neck cancer patients, based on integrated computerized
optimization of beam angles and intensity pro¡les. By using a single wishlist with plan
objectives and constraints for all patients and techniques, plan generation became fully
user independent, ensuring objective plan comparisons. Nine beam plans performed
better than seven beam plans, and coplanar plans with optimized gantry angles had
better gland sparing than equiangular plans. Noncoplanar plans with optimized gantry
and couch angles had the lowest glandNTCPs, although dierences with coplanar plans
with an optimized couch angle were negligible formost patients.
iCycle generatesmulticriterial optimized treatment plans.Other algorithms formul-
ticriterial plan optimization have been evaluated clinically, showing a bene¡t for plan
quality and plan eciency [43,44]. But in these studies the number of treatment beams
and their orientationswere still manually selected.¥e regular labor-intensive trial-and-
error process for selecting beam orientations and number of beams in IMRT treatment
planning may result in variations in plan quality, depending on the skills and experi-
ence of the dosimetrist. Class solutions for beam arrangements may be suboptimal for
individual patients. iCycle is an algorithm for fully automated generation of plans with
optimized beam angles and intensity pro¡les. ¥erefore, the workload for generating
plans is almost negligible. Prior to the start of the investigations described in this paper,
for 10 of the 20 selected patients we compared the clinical plan as generated with the
Monaco TPS with the coplanar iCycle plan with optimized gantry angles (iCyclecopl).
For each of these patients, salivary gland sparing in the iCycle plan was superior. On
average, the mean gland NTCP reduced from 29.2% to 19.4%.
iCycle has been developed in a research setting and not for clinical use; a segmenta-
tion algorithm is currently lacking. However, it turned out that using the optimal beam
angles andmean gland doses as establishedwith iCycle as input,Monaco could be steered
to generate a clinically acceptable plan that was almost identical to the iCycle plan with
respect to the obtained gland NTCPs.¥e procedure for converting an iCycle plan into
a Monaco plan has recently been automated. As a result, high quality IMRT plans for
head-and-neck cancer patients can now be generated in two automated steps.¥e ¡rst
step is generation of a plan in iCycle; the second is the conversion into a clinically de-
liverable Monaco plan. We recently performed a prospective study for head-and-neck
patients, showing a clear bene¡t for this automated plan generation approach [45]. In
that study, we took into accountmore relevant critical structures, like oral cavity, larynx
and swallowing muscles, during plan optimization.
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We demonstrated that iCyclecouch planswere sometimes superior to the correspond-
ing plans for couch angle 0°. ¥is was especially true in unilateral neck treatments, in
which rotation of the couch o¥en resulted in a free projection of the contralateral salivary
glands, yielding reductions in delivered gland doses. As demonstrated for two patients,
also with VMAT the optimal non-zero couch angles resulted in lower salivary gland
doses than plans for couch angle 0°.
All iCycle plans in this study were automatically generated based on one identical
wishlist.¥is allows for anobjective comparison of competing treatment strategies for in-
dividual patients. For none of them, clinically relevant plan improvementswere observed
when using more than nine beams. Patients with unilateral targets showed very little
improvement in plan quality a¥er adding beams eight or nine. However, adding extra
beams never deteriorated plan results.¥e investigations revealed that the gain of more
complex or time-consuming treatment techniques was patient dependent. As planning
with iCycle is fully automated, a possible future clinical application is to generate for each
patient nine-beam coplanar plans for couch angle 0° and several non-zero angles, and a
nine-beam noncoplanar plan. Based on the dierences inNTCP and involved treatment
time, one could then choose for each individual patient the most appropriate treatment
technique.
4.5 Conclusions
iCycle is a novel plan optimization algorithm for user-independent generation of treat-
ment plans with optimized beam angles and intensity pro¡les, allowing objective com-
parison of competing planning strategies. For head-and-neck cancer patients, plan gen-
eration with iCycle can result in improved salivary gland sparing with a largely reduced
planning workload.Observed sparing was best for fully noncoplanar plans.VMAT with
anoptimized couch angle can improve salivary gland sparing compared to the commonly
applied zero couch angle.
chapter 5
Toward fully automated multicriterial plan
generation: a prospective clinical study
PeterW.J. Voet, RTT,Maarten L.P. Dirkx, PhD, Sebastiaan Breedveld, PhD,
Dennie Fransen, RTT, Peter C. Levendag,MD, PhD, Ben J.M.Heijmen, PhD
International Journal of Radiation Oncology Biology Physics; 85(3):866–72 (2013).

Summary | 55
ch
ap
t e
r5
Summary
A randomized, prospective study was performed comparing fully automatically and
manually generated IMRT plans for head-and-neck cancer patients. Of the two plans,
the treating physician selected the plan to be used for treatment. In 97% of cases, the
automatically generated plan was chosen because of the superior quality. In addition to
better sparing of the large majority of critical structures, improved target coverage was
achieved formost patients.
Abstract
Purpose: To prospectively compare plans generated with iCycle, an in-house developed
algorithm for fully automated multicriterial intensity modulated radiotherapy (IMRT)
beam pro¡le and beam orientation optimization, with plans manually generated by
dosimetrists with the clinical treatment planning system.
Methods andMaterials: For 20 randomly selected head-and-neck cancer patients with
various tumor locations (ofwhom 13 received sequential boost treatments)we oered the
treating physician the choice between an automatically generated iCycle plan and aman-
ually optimized plan using standard clinical procedures.While iCycle used a ¡xed ‘wish-
list’ with hard constraints and prioritized objectives, the dosimetristsmanually selected
the beam con¡guration and ¡ne-tuned the constraints and objectives for each IMRT
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plan. Dosimetrists were not informed in advance whether a competing iCycle plan was
made.¥e two plans were simultaneously presented to the physician, who then selected
the plan to be used for treatment. For the patient group,we also quanti¡ed dierences in
PTV coverage and sparing of critical tissues.
Results: In 32/33 plan comparisons the physician selected the iCycle plan for treatment.
¥is highly consistent preference for automatically generated plans was mainly caused
by improved sparing for the large majority of critical structures.With iCycle, the normal
tissue complication probabilities (NTCPs) for parotid and submandibular glands were
reduced by 2.4% ± 4.9% (maximum: 18.5%, p = 0.001) and 6.5% ± 8.3% (maximum: 27%,
p = 0.005), respectively. ¥e reduction in mean oral cavity dose was 2.8 Gy ± 2.8 Gy
(maximum: 8.1Gy, p = 0.005). For swallowing muscles, esophagus and larynx, the mean
dose reduction was 3.3 Gy ± 1.1 Gy (maximum: 9.2 Gy, p < 0.001). In addition, for 15 of
the 20 patients, the target coverage was improved as well.
Conclusions: In97%of cases, the automatically generatedplanwas selected for treatment
because of superior quality.Apart from improved plan quality, automatic plan generation
is economically attractive because of reduced workload.
5.1 Introduction
Intensitymodulated radiotherapy (IMRT) is commonly applied as curative radiotherapy
treatment for head-and-neck cancer patients. As the input for computerized optimiza-
tion of the beam pro¡les, the number of beams, their con¡guration, the constraints,
and objectives need to be de¡ned by the dosimetrist. It is o¥en dicult for dosimetrists
to select these input parameters and to assess whether and how a plan can be further
optimized bymodifying them for a second attempt.¥is can result in a time consuming
trial-and-error process. Moreover, the realized plan quality can depend highly on the
complexity of the case, the time available for plan generation, and the skills and ambition
of the dosimetrist.
In the present study we prospectively compared 2 plans for a group of randomly
selected head-and-neck patients: 1 generated by dosimetrists using the clinical treatment
planning system (Monaco, Elekta AB, Sweden), and 1 using automatic plan generation by
iCycle. iCycle [8,37,38] is an in-house developed algorithm formulticriterial optimization
of beampro¡les and gantry angles.¥epatientswere treated according to the best plan, as
selected by the treating physician. Planswere compared based on physicians’ preferences
and quantitative assessments.
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Table 5.1: Patient characteristics.
Patient Tumor type TNM Dose intervals (Gy) Followed by
1 Hypopharynx Ca. T4aN2bM0 0–66
2 Oral Cavity Ca. T4aN0M0 0–46 + 46–66
3 Tonsil Ca. T2N0M0 0–46 brachytherapy
4 Larynx Ca. T4N2bMx 0–46 + 46–70
5 Larynx Ca. T4aN1M0 0–46 + 46–70
6 Nasopharynx Ca. T1N1Mx 0–46 + 46–70
7 Oral Cavity Ca. T2N0M0 0–46 Cyberknife boost
8 Base of tongue Ca. T2N2bM0 0–46 Cyberknife boost
9 Hypopharynx Ca. T2N2bM0 0–46 + 46–70
10 Sinus piriformis Ca. TxN2bMx 0–46 + 46–66
11 Tonsil Ca. T3N2bMx 0–46 Cyberknife boost
12 Hypopharynx Ca. T4aN0M0 0–46 + 46–70
13 Hypopharynx Ca. T2N0M0 0–46 + 46–70
14 Tongue Ca. T4N2cM0 0–46 + 46–66
15 Larynx Ca. T3N0M0 0–46 + 46–70
16 Base of tongue Ca. T2N0M0 0–46 + 46–70
17 Lip Ca. TxN0M0 0–45 + 45–62.5
18 Left neck(Mesothelioma) 0–44
19 Oral Cavity Ca. T2N0M0 0–66
20 Larynx Ca. T3N0M0 0–46 + 46–70
5.2 Methods andMaterials
Patients
An overview of the 20 patients included in our study is provided in Table 5.1.
¥e treatments for the indicated dose intervals were delivered using an Elekta Syn-
ergy accelerator and 6 MV photon beams. For 13 of the 20 patients, a sequential boost
followed the initial treatment ≤45 or 46Gy. Because boosts deliveredwith brachytherapy
orCyberknifewere excluded in our analyses, the treating physiciansmade in total 33 plan
comparisons and selections.
Before plan generation, the treating physician contoured the CT-scan of the patient,
largely assisted by the autocontouring programABAS [24].Apart from the clinical target
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MONACO
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IMRT dos
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Figure 5.1:WorkDow of this study. Note that both IMRTdos and IMRTiCycle were presented to the treating
physician in the same program (Monaco).
volumes (CTV), the parotid and submandibular glands, oral cavity, swallowing muscles,
¡rst centimeter of the esophagus [4], larynx, spinal cord, and brain stemwere delineated.
For planning, CTVs were extended with a margin of 5 mm to generate planning target
volumes (PTV).
Study design
¥e design of our study is schematically presented in ¡gure 5.1.
During the study period, the standard protocol for IMRT of head-and-neck patients
included “manual” generation of a treatment plan (IMRTdos) by a dosimetrist using our
clinical treatment planning systemMonaco, version 2.04. For each IMRT plan the beam
con¡guration wasmanually selected and the constraints and objectives were ¡ne tuned.
For the study patients, a second plan (IMRTiCycle) was generated, using an automated
plan generation with iCycle [8] (see also next section).Neither the involved dosimetrist,
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nor the treating physician, knew in advance whether a competing iCycle plan would be
developed.
iCycle is not commissioned for clinical use. ¥erefore, 1 of the investigators (PV)
used Monaco for conversion of each iCycle plan into a highly similar, clinically deliv-
erable plans (IMRTiCycle). First, a Monaco plan template was automatically generated,
including the optimized beam angles and achieved plan parameters for organs-at-risk
(OARs) in iCycle.Withminimal user interference, these values could then be reproduced
in Monaco within a 1-Gy dierence for all OARs. To prevent any bias the investigator
(PV) did not have access to the IMRTdos plan while generating the IMRTiCycle plan.
IMRTdos and IMRTiCycle were together presented to the treating physician for plan selec-
tion, using identical lay-outs of plotted dose distributions, and dose-volume histograms.
Seven dosimetrists, experienced in IMRT planning,were involved in generating the stan-
dard plans usingMonaco. Seven head-and-neck radiation oncologists entered the patient
data and evaluated competing IMRTiCycle and IMRTdos plans to select the best plan for
treatment. In addition to physician preference, we compared plans using quantitative
analyses of the achieved PTV coverage and OAR sparing. For patients with a sequential
boost, not delivered with brachytherapy or the Cyberknife, summed dose distributions
were evaluated.¥e target dose was quanti¡ed by the dose delivered to 99% of the target
volume (D99%). For the spinal cord and brainstem, maximumdoseswere compared.¥e
mean doseswere evaluated for the otherOARs. For salivary glands, themean doseswere
converted into normal tissue complication probabilities (NTCP) values, using published
dose-response models for parotid [39] and submandibular glands [40]. Both models are
based on the probability of Grade 4 toxicity (i.e., salivary ¤ow rate <25% of baseline
pre-radiotherapy). For the group of patients, 2-sided Wilcoxon matched-pair signed-
rank tests were used to derive the statistical signi¡cance of observed dierences in plan
parameters.
For both IMRTdos and IMRTiCycle, the required hands-on planning timewas logged.
Time for optimization, segmentation, and dose calculation, which did not require any
manual interference, was excluded.
iCycle plan generation
iCycle is an algorithm for automated multicriterial optimization of both beam orien-
tations and IMRT ¤uence pro¡les. Its features have been previously described in de-
tail [8]. In brief, the basis for plan optimization is an a-priori de¡ned ‘wishlist’ containing
hard constraints to be strictly obeyed and prioritized objectives. Per patient category, a
¡xed wishlist is used. Treatment plan generation is fully automated (i.e., without any
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user interaction such as tweaking of the objectives). ¥e core of iCycle is the 2-phase
ε-constraint algorithm for generating Pareto-optimal plans for preselected (¡xed) beam
arrangements [37,38]. In generated Pareto-optimal plans, none of the objectives can be
improved any further without deteriorating ≥1 constraints or higher prioritized objec-
tives. In iCycle, beam pro¡le optimization is integrated in an iterative procedure for the
selection of optimal beam directions. Starting with 0 beams, new beams with optimal
directions are consecutively selected from a list of candidate beams and added to the
plan. For the selection of the next beam orientations, all candidate beams not yet selected
are temporarily added to the con¡guration established in the previous iteration, and the
IMRT optimization problem is solved. In the end, the orientation with the best score
is added to the beam con¡guration. For each orientation added, this results in 1 new
Pareto-optimal IMRT plan.¥e addition of a new beam improves plan quality regarding
the highest prioritized objective that can still be improved on. In the present study, a total
of 9 directionswere used for plan generation for each patient, resulting in Pareto-optimal
plans with 9, 8, . . . , 1 beams.With more than 9 beams, clinically relevant improvements
were not observed. Using a minimum gain of 0.5 Gy per added beam in at least one of
the objectives,we determined the number of beams for generating the IMRTiCycle plans.
In the present study, iCycle was used to generate Pareto-optimal coplanar plans at couch
angle 0°.¥e beamdirectionswere automatically selected from 72 equi-spaced candidate
directions (5° separation), including 0°.
¥e applied wishlist for the ¡rst dose interval of each patient is listed in Table 5.1.
It was established using the clinical protocol trial runs of iCycle for a small group of
patients, and discussions with 2 of the 7 involved clinicians. iCycle has a mechanism
to reduce, if possible, the objective functions in the wishlist to values lower than the
indicated goal values, with an accent on the objectives with the highest priorities. PTV
coverage had the greatest priority. To enforce that the PTV dose delivered to 99% of the
PTVwas ≥95% of the prescribed dose, the logarithmic tumor control probability (LTCP)
was used [37,41]. For a homogeneous target dose equal to the prescribed dose, LTCP
equaled 1. A lower target dose would result in a strongly enhanced LTCP, and greater
target doseswould decrease the LTCP to aminimum value of 0 for a clinically infeasible,
in¡nite dose.To guarantee good target coverage, an alpha value of 0.8was used.A higher
alpha parameter puts a higher penalty on cold spots in the PTV.A reduction of themean
salivary gland doses was performed using a multi-level approach [24], i.e. by repeated
use of the objective function with decreasing priorities and goal values (Table 5.2).
iCycle ¡rst tried to minimize the mean dose in each of the salivary glands to 39 Gy
(corresponding to an NTCP of about 50%, objective 2), and then to 20 Gy (NTCP of
about 10%, objective 3). Before minimizing the dose in the salivary glands even further
(priorities 9 and 11), the mean oral cavity dose (priority 4), the maximum dose in spinal
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Table 5.2: Applied wishlist for Brst dose interval of each patient, containing hard con-
straints, and prioritized objectives.
Constraints
Volume Type Limit
PTV max 107% of prescribed dose
Spinal Cord max 48 Gy*
UnspeciBed tissue max 107% of prescribed dose
Objectives
Priority Volume Type Goal
1 PTV ↓LTCP 1
2 Parotid/SMG ↓mean 39 Gy
3 Parotid/SMG ↓mean 20 Gy
4 Oral Cavity ↓mean 39 Gy
5 Spinal Cord/Brain Stem ↓max 30 Gy
6 External ring** ↓max 90% of prescribed dose
7 Larynx + swallowing muscles ↓mean 75% of prescribed dose
8 PTV shell 1 cm*** ↓max 75% of prescribed dose
9 Parotid/SMG ↓mean 10 Gy
10 PTV shell 4 cm*** ↓max 40% of prescribed dose
11 Parotid/SMG ↓mean 2 Gy
Abbreviations: LTCP = logarithmic tumor control probability ; PTV = planning target volume; SMG =
submandibular gland.
* For patients treated with a sequential boost technique, a spinal cord constraint of 38 Gy was applied
to leave room for optimizing the boost plan.
** Structure 2 cm distance interior from patient surface, preventing high superficial doses in incident
beams.
*** PTV shells 1 and 4 cm from PTV to control dose gradient outside PTV.
cord and brainstem (priority 5) and the mean dose in the larynx and swallowing muscles
(priority 7) were optimized.When for instance the dose in the oral cavity would not be
considered ¡rst, the salivary glandsmight be spared at the cost of an unacceptable high
dose in the oral cavity.¥e volumes ‘External ring, PTV shell 1 cm and PTV shell 4 cm’
aimed at reduction of the entrance dose, and steering the dose gradient outside the PTV,
respectively.
For patients with a sequential boost (Table 5.1) we used the same wishlist for the
boost.Only the constraints for the spinal cord and brainstemwere adjusted according to
the dose interval.
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5.3 Results
IMRTiCycle and IMRTdos plans consisted of 6–9 beams (average 8.6), and 5–9 beams
(average 7.3), respectively. In 32 of 33 plan comparisons, the physician selected IMRTiCycle
for treatment, in the vast majority of cases because of reduced dose delivery to OARs,
with negligible loss in PTV coverage, equal coverage, or even improved coverage. For
patient 11, IMRTiCycle was selected notwithstanding the higher OAR doses. In this case,
IMRTdos had a too low PTV coverage, which was avoided in IMRTiCycle.
¥e obtained OAR doses are compared in ¡gure 5.2.
In the case of a patient having plans for two dose intervals (see Table 5.1), data for the
summed plan were provided. For the iCycle plans the meanNTCP was reduced by 2.4%
(maximum: 18.5%, p = 0.001) for parotid glands and by 6.5% (maximum: 27%, p = 0.005)
for submandibular glands.¥emean dose in the oral cavity reduced by on average 2.8Gy
(maximum: 8.1Gy, p = 0.005).Amean dose reduction in swallowingmuscles, esophagus
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Figure 5.2:Di>erences inOARmean doses between IMRTdos and IMRTiCycle for the 20 study patients with
at the right end (‘all’) the patient group averages. Positive values indicate lower OAR doses for IMRTiCycle .
Results forOARs that could not be spared, because they are completely embedded in the PTV, were omit-
ted.MCS= musculus constrictor superior;MCM= musculus constrictor medius;MCI= musculus constrictor
inferior;MCP = musculus constrictor cricopharyngeus. SMG = submandibular gland.
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Figure 5.3:Di>erencesbetween IMRTdos and IMRTiCycle inD99% andNTCP values for the individual salivary
glands, for the 20 study patients. Results for salivary glands that could not be spared, because they were
completely embedded in the PTV,were omitted. For points in the upper right quadrant, IMRTiCycle showed
both a better target coverage and improved OAR sparing. SMG = submandibular gland.
and larynx was observed of 3.3Gy ± 1.1Gy (maximum 9.2Gy, p < 0.001). For IMRTiCycle
the maximum doses in the spinal cord and in the brain stem were well below toler-
ance with average values of 34.8 Gy and 21.8 Gy, respectively. Relative to IMRTdos the
maximum doses in the spinal cord and the brain stem were reduced by 3.3 Gy ± 4.0 Gy
(p = 0.04) and 1.1 Gy ± 6.4 Gy (p = 0.531), respectively.
Figure 5.3 illustrates the balance between target coverage and NTCP for the salivary
glands.
Overall, the target coverage was slightly better for the IMRTiCycle plans. ¥e mean
improvement inD99% was 0.24Gy ± 0.4Gy (p = 0.07).Of salivary glands, 75% had lower
NTCPswith the IMRTiCycle plan (upper le¥ and right quadrants in ¡gure 5.3); 59% of the
glands are in the upper right quadrant, indicating that IMRTiCycle had the lowest mean
gland dose, and improved target coverage.
For each patient, we estimated both for IMRTdos and IMRTiCycle the probability that
the function of at least one parotid gland could be preserved, and the probability that at
least one submandibular gland could be spared. ¥ese probabilities, P, were calculated
according to P = (1 − NTCPleft × NTCPright). Figure 5.4 shows clearly that this proba-
bility was greater for the IMRTiCycle plans, except for patient 11 (see ¡gure 5.2). In cases
in which IMRTdos already has a high sparing probability (i.e., close to 100%), there is
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naturally limited room for improvement with IMRTiCycle. However, for patients with a
lower probability of sparing at least one of the glands, sparing could be substantially
enhanced using IMRTiCycle.
¥e average hands-on time spent by dosimetrists on generating an IMRTdos plan
was 3.3 hours (range 1–6.5 hours). As described in the Methods and Materials section,
generating an iCycle plan is fully automated. Conversion into a Monaco plan to arrive
at the clinically applicable IMRTiCycle plan, as performed in this study, took on average
1.5 hours (range 1–2.5 hours).
5.4 Discussion
To our knowledge, this is the ¡rst prospective clinical study evaluating the possibilities
for automated treatment plan generation. We included patients with a broad range of
head-and-neck tumor sites in the present study. For each study patient and dose in-
terval, a plan generated with iCycle, our in-house algorithm for automated, multicri-
terial optimization of beam angles and pro¡les, was compared with a plan manually
generated by the dosimetrists, following the routine clinical protocol. In 32 out of 33
cases, physicians selected the automatically generated plan for treatment. Generally,
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IMRTiCycle plans showed higher quality for a very broad range of plan parameters (see
¡gure 5.2).¥is could explain the high consistence in the physician’s preferences for the
automatically generated plans. Only once did a physician select the IMRTdos plan for
treatment (patient 9; 0–46 Gy). In this case, IMRTiCycle showed larger hotspots (107%
of the prescribed dose) in parts of the PTV adjacent to the parotid glands. ¥at these
hotspots resulted in reduced parotid gland mean doses was considered less important.
With some minor adjustments in the standard wishlist used by iCycle, these hotspots
could have been avoided [37]. For the sequential boost of this patient, the physician
preferred the IMRTiCycle plan for treatment.As demonstrated in previous studies, iCycle
can also be used to fully optimize noncoplanar IMRT plans [8].Comparedwith coplanar
beam arrangements, minor improvements inOAR sparingwere observed formost head-
and-neck cancer patients. Because delivery of noncoplanar plans would be more labor
intensive and time consuming, as techniciansmust enter the room tomanually execute
the prescribed couch rotations, coplanar beam arrangements were used in the present
study.
Using the applied wishlist, with multi-level objectives for the salivary glands, the
sparing of dierent OARs was better balanced with IMRTiCycle. For some patients, this
resulted in less sparing for a lower-prioritized OAR to the bene¡t of higher prioritized
ones.As an example, in patient 1, themean dose in the oral cavity was 1.7Gy greaterwith
the IMRTiCycle plan; however, the sparing of the parotids and le¥ submandibular gland
was improved (mean dose reductions of 2.2 Gy, 3.5 Gy and 4.4 Gy, respectively).
For the patient group, the dierences between IMRTdos and IMRTiCycle, appeared
to be small. Nevertheless, individual patients could bene¡t highly from automated plan
generation with iCycle, as shown by dierences in NTCP values up to 18.5% for parotid
glands and up to 27% for submandibular glands (see ¡gure 5.3).
¥e basis of automated plan generation with iCycle is the automated steering of plan
optimizations, using a wishlist with plan criteria that is identical for all patients. ¥e
observed high clinician preference and the favorable plan parameters for the IMRTiCycle
plans have demonstrated that automated plan generation can be successfully performed.
Asmentioned also in theMethods andMaterials section, the wishlist used in this study
was compiled using discussionswith 2 of the 7 clinicians participating in the study.How-
ever,with the input from only 2 of the clinicians, itwas possible to generate awishlist that
served the needs of the others.
Other recent reports also addressed the possibility of (semi-)automatic treatment
planning. ¥ieke et al. [43] described a multicriterial optimization technique with an
interactive plan navigation tool. ¥ey automatically generated a database with Pareto-
optimal IMRT plans. By interactively exploring this database the optimal treatment plan
was identi¡ed. Teichert et al. [46] enhanced the algorithm such that the user could also
navigate between plans with dierent beam con¡gurations. In contrast to iCycle, the
number of treatment beams and the beam con¡gurations were manually prede¡ned.
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Cra¥ et al. [44] reported on multicriterial plan generation for glioblastoma and pan-
creatic cancer patients, showing clear bene¡ts in treatment planning eciency and plan
quality compared with manually generated treatment plans.¥ey also used a prede¡ned
beam arrangement.
Another limitation of both multicriterial optimization approaches is that manually
selecting an optimal plan from the Pareto front might be very dicult and subjective,
especially whenmany OARs are involved.
Zhang et al. [47] described an algorithm for automatic intensity-modulated radiation
treatment planning for lung cancer. In their work the beam angle con¡guration was
selected from an expert database, depending on tumor size and position. A drawback
of this approach is that it remains unclear whether this con¡guration is optimal for the
next patient.
Asmentioned in theMethods andMaterials section, iCycle currently cannot be used
as adirectmethod for generating clinical plans.¥erefore, in the present study, fully auto-
matically generated iCycle plans were ‘manually’ converted into correspondingMonaco
plans (IMRTiCycle) of highly similar quality. From the superiority of the IMRTiCycle plans
compared with the manually generated plans (IMRTdos), we have concluded that fully
automated planning with iCycle will be feasible, once the system has been prepared for
direct clinical use. For the present study, however, there was also an advantage with the
conversion of the iCycle plans.Because both planswere available inMonaco, the layout of
the presented dose distributions and dose-volume histograms was equal for IMRTiCycle
and IMRTdos, avoiding plan selection bias.
In an ongoing project, we aim at the direct use of iCycle plans in the clinic, avoiding
conversion toMonaco plans.We also have started to routinely apply iCycle for treatment
of head-and-neck cancer patients as described in the present report (i.e., the use of iCy-
cle for generation of an IMRT plan, followed by conversion to a deliverable plan with
highly similar quality in Monaco). More comparative studies are needed to investigate
the importance of automated treatment planning for other tumor sites.
5.5 Conclusions
Compared to plans generated by dosimetrists with Monaco, the plans automatically
generated with iCycle were highly preferred by treating physicians. ¥e results from
quantitative plan analyseswere in linewith this preference. By routinely applying iCycle,
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optimized, patient speci¡c treatment plans can be generated for large groups of patients
with minimal user interaction.
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Abstract
Purpose: To compare IMRT planning strategies for prostate cancer patients with metal
hip prostheses.
Methods and Materials: All plans were generated fully automatically (i.e., no human
trial-and-error interactions) using iCycle, our in-house developed algorithm for multi-
criterial selection of beam angles and ¤uence pro¡les, allowing objective comparison of
planning strategies. For 18 prostate cancer patients (eight with bilateral hip prostheses,
tenwith a right-sidedunilateralprosthesis), twoplanning strategieswere evaluated: i) full
exclusion of beams containing beamlets thatwould deliver dose to the target a¥er passing
a prosthesis (IMRTremove), and ii) exclusion of those beamlets only (IMRTcut). Planswith
optimized coplanar and noncoplanar beam arrangementswere generated.Dierences in
PTV coverage and sparing of organs-at-risk (OARs)were quanti¡ed.¥e impact of beam
number on plan quality was evaluated.
Results: Especially for patients with bilateral hip prostheses, IMRTcut signi¡cantly im-
proved rectum and bladder sparing compared to IMRTremove. For 9-beam coplanar
plans, rectum V60 Gy reduced by 17.5% ± 15.0% (maximum 37.4%, p = 0.036) and rectum
Dmean by 9.4% ± 7.8% (maximum 19.8%, p = 0.036). Further improvements in OAR
sparing were achievable by using noncoplanar beam set-ups, reducing rectum V60 Gy
by another 4.6% ± 4.9% (p = 0.012) for noncoplanar 9-beam IMRTcut plans. Large re-
ductions in rectum dose delivery were also observed when increasing the number of
optimized beam directions in the plans. For bilateral implants, the rectum V60 Gy was
37.3% ± 12.1% for coplanar 7-beam plans and reduced on average by 13.5% (maximum
30.1%, p = 0.012) for 15 directions.
Conclusions: iCycle was able to automatically generate high quality plans for prostate
cancer patients with prostheses. Excluding only beamlets that passed through the pros-
theses (IMRTcut strategy) signi¡cantly improved OAR sparing. Noncoplanar beam ar-
rangements and, to a larger extent, increasing the number of treatment beams, further
improved plan quality.
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6.1 Introduction
With the aging of the population, an increasing number of patients with osteoarthritis
will get a hip replacement. In¥e Netherlands, the incidence of hip implants increased
by 50% between 1995 and 2005, and is expected to increase by another 149% till 2030 [48].
Consequently, the number of prostate cancer patients with ametal hip implant referred
for radiotherapy is expected to grow extensively. For these patients, the search space
for beam angle selection is severely limited.¥e American Association of Physicists in
Medicine (AAPM) Task Group 63 recommends using beam arrangements that com-
pletely avoid dose delivery throughmetal hip prostheses [49].Especially for patientswith
bilateral prostheses, this generally results in less favorable dose distributions since pri-
marily only anterior and posterior beams can be selected. Recently, our group described
a new planning technique that allowed the use of default beam set-ups for patients with
prostheses [50]. Tumor dose delivery through prostheses was avoided by manually de-
lineating prosthesis–avoiding-volumes (PAVs) outside the patient’s body contour, and
putting strict dose constraints on them.Compared to the prostheses-avoiding technique
as suggested by AAPM, better sparing of the organs-at-risk (OARs) and/or an improved
target coverage was obtained. A limitation of this work was that only one patient with a
unilateral and one with a bilateral prosthesis were evaluated. In addition, it is not clear
to what extent the plan quality was aected by the used default set of coplanar beam
orientations.
In this study, dierent treatment planning strategies for patientswith metal implants
were systematically evaluated for 18 prostate cancer patients. For plan generationwe used
iCycle, an in-house developed multicriterial plan generation algorithm with integrated
beam angle and beam intensity optimization [8]. Due to the deterministic approach,
iCycle can be used for objective comparison of dierent planning strategies. Plan gen-
eration with iCycle is fully automated, i.e. there is no manual trial-and-error tweaking
by a dosimetrist to generate an acceptable plan. In a recent prospective clinical study we
reported for a group of head-and-neck cancers patients superiority of plans automatically
generatedwith iCycle, compared to plansmade by dosimetrists [45]. In this study, the au-
tomated plan generation allowed objective comparison of dierent strategies for coping
withmetal hip implants in prostate cancer patients. For each patient,we investigated how
close plan quality could get to the plan for the patientwithout prostheses. Planswith both
coplanar and noncoplanar beam arrangements were evaluated. In addition, the impact
of the number of treatment beams on plan quality was quanti¡ed.
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6.2 Materials andMethods
Patients
From our clinical database, 18 prostate cancer patients treated in our department with
radiotherapy between January 2009 and January 2012 were selected. Eight of them had
bilateral hip prostheses; the other ten patients had a right-sided unilateral hip prosthesis.
Prior to treatment, a computed tomography (CT) scan was acquired using a Somatom
Sensation Open multi-slice CT scanner (Siemens, Erlangen, Germany). For some pa-
tients, also anMR scanwasmade and registered to theplanningCT.¥eprostate, seminal
vesicles, bladder and rectumwere delineated according to the Radiation¥erapyOncol-
ogyGroup (RTOG) guidelines [51]. In addition, the metal hip prosthesis was contoured.
All streak artifacts in theCT images, caused by themetal implants,were given an electron
density override of 1.0 to achieve a more realistic and accurate dose calculation [52].
¥e planning target volume (PTV)was de¡ned by expanding the prostatewith amargin
of 5 mm (7 mm in caudal direction) and the seminal vesicles with a uniform margin
of 8 mm. A total dose of 78 Gy was prescribed to the PTV. For treatment planning, 10
MV photon beams were used, as we clinically use to do for all our pelvic patients treated
with IMRT.
iCycle plan generation
iCycle is an in-house developed algorithm formulticriterial optimization of both IMRT
¤uence pro¡les and coplanar or noncoplanar beam arrangements, described in detail in
[8,37,38]. Starting point for plan optimization is an a-priori de¡ned “wishlist”, containing
hard constraints to be strictly obeyed and prioritized objectives, and a listwith candidate
beam orientations. Per patient category, one ¡xed wishlist is used. For coplanar plans,
72 equi-angular spaced beams at couch angle zero were used as candidate beams. For
noncoplanar plan generation, feasible noncoplanar candidate beams were added to this
list. Simulation at the treatment unit showed that the maximum couch rotation that
avoided any collision was ±20°. In practice, this resulted in a total of 166 noncoplanar
candidate beams.
Treatment plan generation is fully automated, i.e., without any user interaction such
as tweaking of the objective weights and mutual priorities. Core of iCycle is the 2-phase-
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Table 6.1:Appliedwishlist for all study patients. LTCP= Logarithmic Tumor Con-
trol Probability.
Constraints
Volume Type Limit
PTV max 104% of prescribed dose
PTV shell 50 mm max 60% of prescribed dose
UnspeciBed tissue max 104% of prescribed dose
Objectives
Priority Volume Type Goal
1 PTV ↓LTCP 0.5
2 PTV shell 5 mm ↓max 95% of prescribed dose
3 Rectum ↓mean 33% of prescribed dose
4 PTV shell 15 mm ↓max 70% of prescribed dose
5 PTV shell 25 mm ↓max 50% of prescribed dose
6 External ring ↓max 50% of prescribed dose
7 Bladder ↓mean 60% of prescribed dose
8 UnspeciBed tissue ↓mean 10 Gy
ε-constraint (2pεc) algorithm for generating Pareto-optimal IMRT plans for preselected
(¡xed) beam arrangements. In these Pareto-optimal plans, none of the objectives can
be improved any further without deteriorating higher prioritized objectives or violating
constraints. In iCycle, beam pro¡le optimization is integrated in an iterative procedure
for selectionof beamorientations. Startingwith zero beams,new beams are consecutively
selected from a list of candidate beams. First, all candidate directions not yet selected
are temporarily added to the con¡guration established in the previous iteration, and the
IMRT optimization problem is solved. In the end, the best scoring orientation is added
to the beam con¡guration, resulting in one new Pareto-optimal plan [8].
Table 6.1 shows the wishlist that was used for all plan generations in this study. PTV
coverage had the highest priority. To enforce that the dose delivered to 99% of the PTV
was at least 95% of the prescribed dose, we used the Logarithmic Tumor Control Proba-
bility (LTCP) [37,41]. For a homogeneous target dose, equal to the prescribed dose, LTCP
equals 1. A lower target dose results in a strongly increased LTCP, while higher target
doses decrease the LTCP to aminimum value of 0 for a clinically infeasible, in¡nite dose.
To guarantee good target coverage, an alpha value of 0.8 was used. A higher alpha puts a
higher penalty on cold spots in the PTV.Objectiveswith decreasing prioritieswere set to
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themean rectum and bladderdoses.A constraintwas used to avoid anydoseshigher than
60% of the prescribed dose at 50 mm from the PTV. In addition, to achieve steep dose
fall-o outside the PTV and suppress high doses in the rectum, objectives for three shells
around the PTV (with priorities 2, 4 and 5) were de¡ned. Tominimize entrance dose we
applied an objective for an external ring, 2 cm inside the patient body contour. In the
¡rst phase of the 2pεc optimization, objectives are optimized to their goal, if achievable,
and then constrained. In the second phase, all objectives are processed again in priority,
but now to their fullest extent [8].
Planning strategies
For patients with bilateral hip prostheses, iCycle generated coplanar and noncoplanar
IMRT plans for two planning strategies. In accordance with AAPM task group re-
port 63 [49], coplanar andnoncoplanar IMRTremove planswere generated inwhich beams
that (partly) entered through a metal hip prosthesis before PTV dose delivery were ex-
cluded from the list of feasible candidate beams used in the plan generation process (see
previous section). For the second strategy, IMRTcut planswere generated inwhich all fea-
sible candidate beamdirectionswere allowed, but any¤uence delivery throughprosthetic
devices at the entrance side of the PTV was prevented in order to limit uncertainties in
dose delivery to the target and organs-at-risk due to inaccuracies in the dose calculation
algorithm caused by high-densitymaterial. To achieve this, iCycle automatically set the
¤uence of beamlets, corresponding to the projection of the prostheses in front of thePTV,
including a margin of 5 mm to account for set-up uncertainties and rounding errors as
a result of the ¡nite ¤uence grid size, to zero. Depending on the size of the prosthesis
and the PTV, and the mutual distance, only 25–40 coplanar candidate beams (from the
original 72 beams) remained available for coplanar IMRTremove and 55–82 noncoplanar
beams (from the original 166) for noncoplanar IMRTremove. In the IMRTcut strategy, also
beamlets in a margin of 5 mm around the PTV projection were excluded. By using this
additional margin any deviations in dose delivery resulting from irradiation through a
prosthesis is avoided in case of errors in patient positioning.A 5 mmmarginwas consid-
ered acceptable due to the daily performed inter- and intra-fraction set-up corrections
for prostate cancer patients, based on implanted gold markers and the intra-fraction
StereoGraphic Targeting (iSGT) approach [53,54]. For less strict procedures for prostate
set-up veri¡cation and correction, the margin should be enlarged.
For comparison, iCyclewas also used to generate coplanar and noncoplanar plans in
which a bone override (with a uniform relative electron density of 1.7) was assigned to
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the metal implants (IMRTbone). In this way we were able to benchmark the IMRTremove
and IMRTcut plans against plans that could be achievable if the patient would not have a
metal hip implant.
¥e above described coplanar IMRTremove, IMRTcut, and IMRTbone plans were also
generated for patients with a unilateral hip prosthesis. In addition, for 3 patients non-
coplanar IMRTcut planswere generated.All iCycleplanswere generatedwith amaximum
of 9 beam orientations, except for the coplanar IMRTcut strategy forwhich up to 15 beams
were used.
Plan evaluation
For all plans, the volume of the PTV receiving at least 95% of the prescribed dose (V95%)
was assessed. For the rectum, we evaluated the mean dose (Dmean) and the percentage
rectum volume receiving more than 60Gy (V60 Gy).¥e latter is associated with the risk
ofGrade ≥2 rectum toxicity, and rectal bleeding [55]. For the bladder, the mean dosewas
scored and the bladder volume receiving more than 65 Gy (V65 Gy) and 70 Gy (V70 Gy)
respectively [56]. AWilcoxon signed rank test was used to determine the statistical sig-
ni¡cance of the dierences between dierent planning approaches.
6.3 Results
Patients with bilateral hip prostheses; 9-beam plans.
In¡gure 6.1 achieved dose distributions arepresented for one of thepatientswithbilateral
metal hip prostheses. Clearly, for the coplanar IMRTremove technique, a wide range of
lateral treatment beams could not be selected in the plan, resulting in a high dose re-
gion that stretched into antero-posterior direction.¥is also applied for the noncoplanar
IMRTremove plan (not shown). For coplanar IMRTcut, more dose was delivered from
lateral directions (although complete lateral beams were not selected either), yielding
steeper dose fall-o toward the rectum and the surrounding areas. With noncoplanar
IMRTcut the dose to the rectum could be further reduced. When comparing this plan
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Figure 6.1: Dose distributions of 9-beam plans for a patient with bilateral metal hip prostheses. Each line
represents a selected beam orientation.
with the noncoplanar IMRTbone plan, dierences in PTV coverage and OAR sparing
were fairly small.
¥e obtainedV95% for the PTVwas at least 99%, except for one case. For this patient,
due to the restrictions in selectable beam orientations, V95% was only 22.3% for coplanar
IMRTremove, compared to 99.1% for coplanar IMRTcut. Improvement in target coverage
was only possible with a higher dose in all OARs. For the other patients, rectum and
bladder sparing were signi¡cantly improved when using coplanar IMRTcut instead of
coplanar IMRTremove (see ¡gure 6.2a). On average, rectum V60 Gy was reduced by 17.5%
± 15.0% (maximum reduction 37.4%, p = 0.036) and rectum Dmean by 9.4 Gy ± 7.8 Gy
(maximum reduction 19.8 Gy, p = 0.036) (see ¡gure 6.3). Due to the lower bladder pri-
ority in the wishlist (see Table 6.1), improvements in bladder sparing were smaller than
for rectum. Nevertheless, dierences in bladder Dmean up to 10.8 Gy and in V65 Gy and
V70 Gy up to 23.5% were observed.OAR sparing could be further improved, although by
a smaller amount, by using optimized noncoplanar instead of coplanar beam arrange-
ments. For rectum V60 Gy and rectum Dmean, and bladder V65 Gy the dierences with
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Figure 6.2: Comparison of rectum and bladder doses for coplanar IMRTcut , IMRTremove , and IMRTbone, and
noncoplanar IMRTcut plans. All markers represent anOAR value for one of the eight patients with bilateral
hip prostheses.
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Figure 6.3: Improvements in rectum and bladder sparing for the di>erent approaches with respect to
coplanar IMRTremove for patients with bilateral hip prostheses. The error bars indicate the observed maxi-
mum and minimum values. All di>erences marked by *were not statistically signiBcant (p > 0.05).
coplanar IMRTcut arrangementswere statistically signi¡cant.On average, rectumV60 Gy
was reduced by 4.6% ± 4.9% (maximum reduction 15.5%, p = 0.018), rectum Dmean by
3.9 Gy ± 3.0 Gy (maximum reduction 9.4 Gy, p = 0.017), and bladder V65 Gy by 4.3% ±
4.2% (maximum reduction 11%, p = 0.043).
Figure 6.2demonstrates thatwhilemoving fromcoplanar IMRTremove (b) to coplanar
IMRTcut (c) to noncoplanar IMRTcut (d), rectum and bladder dose-volume parameters
gradually decrease toward coplanar IMRTbone values, i.e. the values that could be ob-
tained for a patient without hip implant.
Patients with a unilateral hip prosthesis; 9-beam plans.
When comparing coplanar IMRTcut with coplanar IMRT remove plansminor dierences
were observed. Only for one patient bladder Dmean was reduced by 1.9 Gy; for the other
patients the dierences for the evaluated parameters for rectum and bladder sparing
remained within 0.8Gy or 1%.¥e results were also very close to the values for coplanar
IMRTbone, showing group average dierences in rectum and bladderDmean within 1.4Gy
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and rectum V60 Gy within 1%. Only for two patients the dierences in rectum Dmean ex-
ceeded 0.8Gy and in rectumV60 Gy 0.7%. For the patient showing the largest dierences
between coplanar IMRTcut and coplanar IMRTbone, and two other, randomly selected
patients, the impact of using an optimized noncoplanar beam setup was investigated.
Only for the ¡rst patient, a clear improvement in plan quality was observed, with dier-
ences in rectum V60 Gy of 11% and in rectum Dmean of 13.3 Gy. Compared to the other
patients, this patient had a relatively large PTV, combined with a substantial amount of
metal around the acetabulum.
Impact of the number of beams on plan quality
Figure 6.4 shows the dependence of dose-volume parameters for PTV, rectum and blad-
der on the number of selected optimized beam directions in coplanar IMRTcut plans.
For patients with bilateral hip prostheses the objective for target coverage could not be
achieved in 2 of the 8 patients when using 5 beams only, yielding a V95% for the PTV of
89.3% and 86.7%, respectively. Using 9 beams instead of 7 beams resulted in a reduction
in rectumV60 Gy of 7.0 ± 6.6% (p = 0.012) and in rectumDmean of 5.3 ± 2.3Gy (p = 0.017).
Adding another 6 beams resulted in a further improvement in rectum sparing, reducing
V60 Gy by 6.4 ± 4.7% (p = 0.012) and Dmean by 6.9 ± 1.4 Gy (p = 0.012). Due to the lower
bladder priority in thewishlist (see Table 6.1), the number of beams had a smaller impact
on bladder sparing.
For patients with a unilateral hip prosthesis adequate target coverage was already
achieved for the 5-beam IMRTcut plans. Nevertheless, also for this group, adding more
beams resulted in a better rectum sparing. When using 9 beams instead of 7, rectum
V60 Gy was reduced by 3.1 ± 0.5% (p = 0.005), and rectum Dmean by 3.0 ± 0.1 Gy
(p = 0.007). When using 15 instead of 9 beams these values got lower by 4.3 ± 0.7%
(p = 0.005) and 4.9 ± 0.3 Gy (p = 0.005).
6.4 Discussion
Radiotherapy treatment of prostate cancer patients with unilateral or bilateral metal hip
prosthesis is challenging.According to recommendations of theAAPM taskgroup 63 [49],
the use of beams that irradiate the PTV through a prosthesis should preferably be
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Figure 6.4: Dependence of dose-volume parameters for PTV, rectum and bladder on the number of op-
timized beam directions in coplanar IMRTcut plans. Mean di>erences with respect to 9-beam plans are
presented for patients with bilateral hip prostheses (A) and a unilateral hip prosthesis (B).
avoided, due to uncertainties in the dose calculation in the vicinity of prostheses formost
commercially available treatment planning systems (TPS). In this studywe systematically
compared this planning technique (IMRTremove)with a strategy that only excluded those
beamlets from the optimization that would deliver dose to the PTV while ¡rst passing
through an implant (IMRTcut). With this latter strategy signi¡cant reductions in dose
delivery to the rectum and bladder could be obtained (see ¡gures 6.2 and 6.3), being
attributed to the enhanced freedom in selecting beamlets with largely lateral PTV irra-
diation.
As shown in ¡gure 6.4, increasing the number of treatment beams will improve rec-
tum sparing. Compared to 9-beam noncoplanar plans, a similar rectum sparing could
be achieved by using 11–13 coplanar beams for all patients. With a larger number of
beams, the patient volume treated to a low dose will increase, but we consider this a
minor limitation.¥e number of monitor units does not necessarily increase for larger
numbers of treatment beams, but treatment delivery times will generally be longer due
to the time needed for setting up and veri¡cation of each beam. To even a larger extent
this also applies when using noncoplanar beam set-ups, since technicians have to enter
the room for couch adjustments. For prostate cancer patients a longer treatment delivery
time may have a large impact on intra-fraction motion [54].¥erefore, in our clinic, a
maximum of 9 coplanar beams is used for treatment of prostate cancer patients, unless
we expect a clear, clinically relevant bene¡t with respect to rectum sparing of the use of
larger numbers of coplanar beams. In our study we did not evaluate VMAT, allowing
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much shorter treatment delivery times, because iCycle does not yet support this.We are
currently working on this.
As explained in the materials and method section, during plan generation iCycle
consecutively adds new beam orientation to the plan, based on the already available con-
¡guration. In other papers, we have demonstrated that very good plansmay be obtained
in thisway.However, there is no proof that thismethodwill result in the overall best plan.
Certainly, from a theoretical point of view there are reasons to believe that there will be
plans that are suboptimal. To what extent this is problematic and how o¥en it occurs is
part of further study. Anyway, because of the high quality of the iCycle plans compared
to the manually generated plans [8],we believe that this issue is of minor importance for
clinical practice. Because in this comparative study all iCycle planswere generated in the
same way, it does not aect the conclusion of our work either.
Recently, Brooks et al. [57] compared coplanar and noncoplanar IMRT plans for one
prostate cancer patient, using beams that fully avoided the prosthesis but not always
covered the entire PTV. For the noncoplanar plan, a better rectum sparingwas reported,
but a larger bladder volumewas exposed to doses up to 50Gy.With our IMRTcut strategy
the dose delivered to both rectum and bladder could be reduced formost patients.
Kling et al. reported the comparison of 7 static ¡elds IMRT with 2–4 partial arc
Tomo¥erapy plans for patients with bilateral metal hip prostheses [52]. For all plans,
a completelymetal-avoiding strategy was used, like our IMRTremove approach. For both
techniques they observed a vast antero-posterior dose delivery, resulting in unacceptably
large amount of high dose outside the PTV. Previously, for two patients we simulated
irradiation with the IMRTcut strategy in a commercial TPS (Monaco 3.1, Elekta, AB),
using PAVs to eectively block beamlets thatwould ¡rst pass prostheses and then deliver
dose to the PTV [50]. For both patients, the simulated IMRTcut strategy, using the default
beam setup for prostate cancer patients without implants, resulted in improved OAR
sparing compared to IMRTremove with manually selected beam orientations. In this pa-
per, iCycle was used for integrated beam angle selection and IMRT optimization, giving
opportunities to further enhance OAR sparing with IMRTcut compared to the default
beam set-up (not investigated here). For each patient iCycle automatically provided a
patient-speci¡c set of beam orientations, depending of the patient anatomy and the size
of the prostheses (see ¡gure 6.1 for an example). Even for patients with a unilateral hip
prosthesis, we were not able to extract a class solution for the beam con¡guration from
these iCycle results.
Although in the IMRTcut strategy ¤uence delivery is avoided for beamlets thatwould
deliver dose to the PTV a¥er passing a prosthesis, the dose delivered to the prostheses
might be underestimated in case the MLC dose leakage is not properly taking into ac-
count in the TPS. Since in all our plans the maximum dose in the prostheses remained
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below 44 Gy and the dose contribution due to leakage was always less than 1 Gy, we do
not consider this a risk for the patient.
Especially for patients with bilateral hip prostheses, delineation of the prostate is
o¥en hampered due to severe streaking artifacts in the planning CT scans. To improve
delineation accuracy, fusionwith anMR scan is highly recommended.Not for all patients
in this study thiswas performed.Butwe think this does not impact ourmain conclusions
regarding the comparison of the planning strategies.
In our study we used a 10 MV photon beam for all plans. Previously, we have seen
that when using more than ¡ve treatment beams for prostate cancer, the selected beam
energy is of minor importance.¥is is also supported by literature (eg. [58]).¥erefore,
we expect similar improvements in plan quality with IMRTcut when using either lower or
higher photon energies. Attenuation of the treatment couch was not taken into account
during plan generation. By taking into account the optimized ¤uences for some beam
directions would somewhat change, but the ¡nal dose distribution would be similar.
We demonstrated for each of the eight patients with bilateral implants clear su-
periority of the IMRTcut planning strategy compared to the IMRTremove approach. In
principle, IMRTcut can be simulated in a commercial TPS with the previously described
PAVs.However, this is time-consuming, so we encourage TPS vendors to implement an
IMRTcut solution as described in this paper.
6.5 Conclusions
For prostate cancer patients with metal hip implants, iCycle was able to automatically
generate high quality, patient-speci¡c IMRT planswith optimized coplanar or noncopla-
nar beam arrangements. Excluding only beamlets that delivered dose to the PTV a¥er
passing through prostheses signi¡cantly improved OAR sparing for patients with bilat-
eral implants as opposed to the AAPM taskgroup 63 recommendation to fully exclude
beams containing such beamlets. Noncoplanar beam arrangements and, to a larger ex-
tent, increasing thenumber of optimized treatment beams further improved plan quality.
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Summary
A system for fully automated volumetric modulated arc therapy (VMAT) treatment
planning for prostate cancer patients was developed and evaluated. Plan quality in auto-
matically generatedVMAT planswas similar tomanually generatedVMAT plans,while
saving at least one hour hands-on time. Based on these results, clinical implementation
has been started.
Abstract
Purpose: To develop and evaluate fully automated VMAT treatment planning for
prostate cancer patients, avoiding manual trial-and-error tweaking of plan parameters
by dosimetrists.
Methods and Materials: A system was developed for fully automated generation of
VMAT plans with our commercial clinical TPS, linked to the in-house developed
Erasmus-iCycle multicriterial optimizer for pre-optimization. For 30 randomly selected
patients, automatically generatedVMAT plans (VMATauto)were comparedwithVMAT
plans generated manually by one expert dosimetrist in the absence of time pressure
(VMATman).For all treatment plans,planning target volume (PTV) coverage and sparing
of organs-at-risk (OARs) were quanti¡ed.
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Results: All generated plans were clinically acceptable and had similar PTV coverage
(V95% > 99%). For VMATauto and VMATman plans theOAR sparing was similar as well,
while only the former plans were generated without any planning workload.
Conclusions: Fully automated generation of high quality VMAT plans for prostate can-
cer patients is feasible and has recently been implemented in our clinic.
7.1 Introduction
For several years, intensity modulated radiotherapy (IMRT) has been used at a large
scale as curative treatment for prostate cancer patients.More recently, volumetric mod-
ulated arc therapy (VMAT) is increasingly being used as an eective and time ecient
alternative [59]. Due to shorter treatment delivery times, application of VMAT might
also reduce the potential impact of intra-fraction prostate motion [54]. Like for static
gantry IMRT planning, generation of an optimalVMAT plan is not straightforward and
o¥en time consuming.Dosimetrists have to select the optimization parametersmanually
and modify them in a trial-and-error process. ¥e quality of the ¡nal treatment plan
depends on the skills and experience of the dosimetrist, the complexity of the case, and
the available time for plan generation.
Recently, we developed Erasmus-iCycle, an algorithm for fully automated, multicri-
terial beam pro¡le optimization and beam angle selection for coplanar and noncoplanar
IMRT [8,45,60,61].Mainly because of (small) inaccuracies in the ¡nal patient dose distri-
bution, Erasmus-iCycle can currently not be used for automated generation of clinically
deliverable plans. In a prospective clinical study, we compared an Erasmus-iCycle based
semi-automated planning procedure for treatment of head-and-neck cancer patients
with the regularmanual plan generation by dosimetrists [45]. For semi-automated plan-
ning, Erasmus-iCycle was used for pre-optimization by fully automatically generating a
plan with optimized ¤uence pro¡les and beam angles. One of the investigators (P.W.J.
Voet) then reconstructed the plan in the clinical treatment planning system (TPS). In
parallel, for each patient, a manual IMRT plan was created by a dosimetrist without
input of Erasmus-iCycle, using the clinical TPS and following the clinical procedures.
In 97% of cases, physicians selected the semi-automatically generated plan for treatment.
¥e procedure both resulted in a higher plan quality and reduced the planning hands-
on time by 50% compared to manual planning. Improved plan quality with Erasmus-
iCycle was also observed for prostate SBRT (stereotactic body radiation therapy) [61]. In
Materials andMethods | 89
ch
ap
t e
r7
that study we also demonstrated higher plan quality for optimized, noncoplanar beam
arrangements compared to coplanar.
In this study we develop and evaluate a fully automatedVMAT planning strategy for
prostate cancer patients. Erasmus-iCycle is still used as pre-optimization for generation
of VMAT plans in the clinical TPS, but we realized a fully automated reconstruction of
Erasmus-iCycle plans inMonaco, avoiding manual plan reconstruction by dosimetrists
as used in [45]. For 30 prostate cancer patients we compared automatically generated
VMAT plans (VMATauto) with VMAT plans generated by one expert dosimetrist (P.W.J.
Voet) (VMATman).
7.2 Materials andMethods
Study patients
From our clinical database, we randomly selected 30 prostate cancer patients, 10 from
each risk groups (see Table 7.1), who were irradiated in our department with curative
intent between January 2012 and January 2013.All patientshad 4 implanted gold ¡ducials,
used for both inter- and intra-fraction set-up corrections [54].
For all patients, a computed tomography (CT) scan was acquired using a Somatom
SensationOpenmulti-sliceCT scanner (Siemens,Erlangen,Germany).Prostate, seminal
vesicles (for groups 2 and 3 patients), bladder, rectum, anus, and hips were delineated
according to the Radiation¥erapy Oncology Group (RTOG) guidelines [51].¥e PTV
was de¡ned by expanding the prostatewith amargin of 5 mm (7mm in caudal direction)
Table 7.1: Grouping criteria for prostate cancer patients, based on the risk of tumor involvement in the
seminal vesicles.
T1-T3a T3b, T4
Gleason score PSA ≤ 4 4 ≤ PSA ≤ 10 PSA ≥ 20 any PSA
2–6 group 1 group 1 group 2 group 3
7 group 1 group 2 group 2 group 3
8–10 group 2 group 2 group 3 group 3
PSA = prostate-specific antigen
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and, for groups 2 and 3 patients, the seminal vesicles with a uniformmargin of 8 mm, as
derived byMutanga et al. [62]. All patients were irradiated with a step-and-shoot IMRT
technique. Patients in groups 1 and 3 were treated with 78 Gy to the PTV, delivered in
39 fractions. For group 2 patients, a simultaneous integrated boost technique was used,
delivering in 39 fractions 78 Gy to the prostate PTV and 72.2 Gy to the seminal vesicles
PTV.
VMAT plan generation
Automated VMAT plan generation using Erasmus-iCycle
A¥er delineation of the organs-at-risk, prostate, and, if applicable, seminal vesicles, and
applying CTV-PTV margins, VMATauto plans were generated fully automatically in a
two-step approach. First, Erasmus-iCycle was used to automatically generate a 23-beam,
equiangular IMRT plan with 10MV photon beams. Based on achieved constraints and
objective values in this plan, a VMAT plan template for our clinical TPS (Monaco ver-
sion 3.3, Elekta AB, Stockholm, Sweden) was generated. Next, the patient was automati-
cally selected inMonaco. Based on the patient-speci¡c template, a clinically deliverable
single arcVMAT planwas generatedwithout any user interaction. For the ¡nal dose cal-
culation inMonaco, the implementedMonte Carlo dose calculation engine was applied.
A¥er ¡nishing, VMATauto plans were automatically saved inMonaco for review.
In [8] Erasmus-iCycle is described in detail. Fully automated plan generation with
Erasmus-iCycle is based on a planning “wishlist”, containing hard constraints to be
strictly obeyed and prioritized objectives, and a list with candidate beam orientations.
Core of Erasmus-iCycle is the 2-phase ε-constraint (2pεc) algorithm for generating
Pareto-optimal IMRT plans for preselected (¡xed) beam arrangements. In this study,
this con¡guration consisted of 23 equi-angular beams. For a subset of prostate cancer
patients we found that by using more than 23 beams plan quality did not improve, while
calculation times increased.
All Erasmus-iCycle plans in this study were optimized using one ¡xed wishlist (see
Table 7.2).¥iswishlistwas a priori established/tuned in a collaboration between treating
physicians, dosimetrists and physicists by iterative planning, plan evaluation, and wish-
list adjustments for a small group of test patients. First priority was PTV coverage. To
ensure that the dose delivered to 99% of the PTVwas at least 95% of the prescribed dose,
we used the Logarithmic TumorControl Probability (LTCP, [41]),with a ¡xed sensitivity
value (alpha) of 0.8. For a homogeneous target dose, equal to the prescribed dose, LTCP
equals 1. A lower target dose results in a strongly increased LTCP, while higher target
doses decrease the LTCP to a minimum value of 0 for a clinically infeasible, in¡nite
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Table 7.2: Applied wishlist for all study patients. LTCP = logarithmic tumor control proba-
bility. gEUD = generalized equivalent uniform dose.
Constraints
Volume Type Limit
PTV max 104% of prescribed dose
PTV shell 50 mm max 60% of prescribed dose
UnspeciBed tissue max 104% of prescribed dose
Right + left hip max 40 Gy
Objectives
Priority Volume Type Goal
1 PTV ↓LTCP 0.5
2 Rectum ↓gEUD (parameter 12) 40% of prescribed dose
3 Rectum ↓gEUD (parameter 8) 25% of prescribed dose
4 Rectum ↓mean 33% of prescribed dose
5 External ring ↓max 40% of prescribed dose
6 PTV shell 5 mm ↓max 93% of prescribed dose
7 Anus Dmean ↓mean 10% of prescribed dose
8 PTV shell 15 mm ↓max 70% of prescribed dose
9 PTV shell 25 mm ↓max 50% of prescribed dose
10 Bladder ↓mean 60% of prescribed dose
11 Right + left hip ↓mean 25% of prescribed dose
12 UnspeciBed tissue ↓mean 10 Gy
dose. Objectives with decreasing priorities were set to the rectum, anus, bladder and
hips. To minimize the rectum volume treated to a high dose, a generalized equivalent
uniform dose objective (gEUD, [63]) with volume parameter a=12 was used (priority 2).
¥e volume treated to intermediate to high doses was further suppressed byminimizing
a gEUDwith a=8 (priority 3).Using amean dose objective, the rectum volume treated to
lower doseswasminimized aswell (priority 4). To realize a steep dose fall-o outside the
PTV, one constraint and three objectives (with priorities 6, 8 and 9) for shells around the
PTV were de¡ned. In addition, an objective for an external ring, 2 cm inside the patient
body contour, was used to minimize the entrance dose (priority 5). In the ¡rst phase
of the 2pεc optimization, starting with the priority 1 objective, objective functions were
consecutivelyminimized, but not below the prescribed goal values asmentioned in Ta-
ble 7.2, and then ¡xed as a constraint forminimization of lower prioritized objectives. In
the second phase, all objectives were again consecutivelyminimized according priority,
but now to the fullest extent.
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Manual VMAT plan generation
As a benchmark for VMATauto plans, one expert dosimetrist (PV) used the clinical TPS
tomanually generate VMATman plans, without any knowledge of the VMATauto results.
Like for VMATauto, a single arc rotation with a 10 MV photon beam was used. Group
based templateswith dose constraints used for generation of clinical IMRT planswere se-
lected as starting point forVMATman plan generation.During optimization, the template
parameters were manually tweaked to improve plan quality. In contrast to the general
clinical practice, the expert dosimetrist could generate the VMATman plans without a
strong clinical time pressure. A maximum of 4 hours of hands-on planning time was
used.
Plan evaluation
For all plans, the volume of the PTV receiving at least 95% of the prescribed dose (V95%)
and the volume receiving more than 107% (V107%) were determined. For the rectum, the
mean dose (Dmean) and the volume percentages receiving more than 60Gy (V60 Gy) and
more than 75 Gy (V75 Gy) were evaluated. Both V60 Gy and V75 Gy are associated with the
risk of Grade ≥2 rectum toxicity, and rectal bleeding [55]. For the bladder, Dmean and
the volume receiving more than 65 Gy (V65 Gy) were quanti¡ed [56].¥e mean dose in
the anus and the maximum dose in the hips were also derived. Two-sided Wilcoxon
matched-paired signed rank tests were used to assess statistical signi¡cance of observed
plan parameters dierences between VMATauto and VMATman.
7.3 Results
For all plans,V95% for the PTVwas at least 99%, and PTV doses higher than 107% did not
occur. Statistically signi¡cant dierences in target coverage were not observed between
VMATman, and VMATauto plans (p ≥ 0.44).
Between VMATauto and VMATman only small dierences in rectum, anus and blad-
der plan parameterswere observed (Figure 7.1 andTable 7.3).While for patients in groups
1 and 2, rectum V60 Gy and Dmean were slightly lower for VMATauto, dierences were
statistically insigni¡cant for all other parameters.
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Figure 7.1:Comparison of rectum, bladder and anus plan parameters between VMATauto and VMATman for
the three study groups. Each marker represents a parameter comparison for one of the study patients. For
data points to the right of the unity line VMATauto yielded better sparing.
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Compared to VMATman plans, VMATauto plans were generated with a vast reduc-
tion in workload. Excluding the time for contouring, generation of the VMATman plans
took on average 5 hours, including 3 hours hands-on time. In contrast, with our current
hardware and so¥ware, generation of theVMATauto plans took about two hours and did
not require any user interaction. Half of the time was spent on the pre-optimization in
Erasmus-iCycle and half of the time on reconstruction of a clinically deliverable plan in
Monaco. As explained before, both steps were sequentially performed in an automated
way.
7.4 Discussion
¥e purpose of this study was development and evaluation of a procedure for fully au-
tomated VMAT plan generation for prostate cancer patients to replace manual IMRT
planning as previously used in our clinic. While in a previous study [45] dosimetrists
still had tomanually reconstruct the automatically generated Erasmus-iCycle plan in the
clinicalTPS to obtain a clinicallydeliverable treatment plan, thismanualplan reconstruc-
tion was now also replaced by automation. As demonstrated in Figure 7.1 and Table 7.3,
dierences between VMATauto and VMATman plans were small and not consistent.¥e
conclusion from this observation is that even an expert dosimetrist, in the absence of
time pressure, could not beat the procedure for fully automated plan generation.
We also compared theVMATauto plans to the clinically applied step-and-shoot IMRT
plans. In all patients a large and consistent improvement in plan quality was observed for
theVMAT plans. RectumV75 Gy,V60 Gy, andDmean, and anusDmean were reduced by up
to 6.1%, 16.7%, 15.4 Gy, and 18.4 Gy, respectively. Formost patients, doses in the bladder
and thehipswere largely reduced aswell, showing dierences up to 12Gy inbladdermean
dose and maximum dose in the hips.We believe that the observed large dierences in
plan quality are mainly caused by variability in planning skills and experience among
our dosimetrists and by limitations in available planning time in the clinical setting.
Previously,we also observed this in our prospective study with Erasmus-iCycle for head-
and-neck cancer patients [45].
Based on the results in this paper, we have recently started clinical implementa-
tion of the fully automated VMAT plan generation. For the ¡rst ten patients, we asked
dosimetrists to attempt improving the VMATauto plans by manually tweaking the plan
objectives inMonaco in a trial-and-error procedure, as normally done in clinical prac-
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tice. Amaximum hands-on time of 1 hour was allowed, corresponding to total planning
times of up to 3 hours. For all patients, the VMATauto and manually tweaked VMAT
plans had similar PTV coverage; the mean V95% was 99.5% ± 0.2% (1SD), p = 1.0. Also
dierences in rectum V75 Gy and V60 Gy (0.1% ± 0.5% (1SD), maximum 1%) were sta-
tistically insigni¡cant (p ≥ 0.54). In case of a slight reduction in V75 Gy or V60 Gy by
manual tweaking for an individual patient, this minor improvement generally resulted
in an increased dose delivery to other, lower prioritized OARs and/or in a deteriorated
dose fall-o in unspeci¡ed tissues. For all patients, the treating physician selected the
VMATauto plan for treatment. Because of the success of the VMATauto procedure, we
have decided that manual VMAT planning will not become part of our clinical routine
for prostate cancer patients.
As explained in detail in thematerials andmethods section, theVMATauto procedure
developed in this study is a two-step process, using sequentially two independent opti-
mizers. In on-going research projects, automated plan generationwith a single optimizer
is pursued. In this study, 23-beam equi-angular IMRT plans, automatically generated
with Erasmus-iCycle, were used as input for VMATauto plan generation in the clini-
cal TPS. Fixed beam plans were used because VMAT plan generation is currently not
yet supported by Erasmus-iCycle. In previous studies, signi¡cant improvements in plan
quality were observed when increasing the number of beam directions [60,61]. In this
study the optimal number of beams was 23; with less beams plan quality was deteri-
orated for some patients, and the use of more beams only increased calculation times
in Erasmus-iCycle. For prostate cancer patients treated with static ¡eld IMRT, Quan et
al. [64] also reported an improvement in plan quality when increasing the number of
beams up to 24. In their study, static gantry IMRT plans with 8 beams showed a similar
plan quality as VMAT plans. To guarantee a smooth transition from Erasmus-iCycle to
the clinical TPS, in this study, the Erasmus-iCycle wishlist was constructed with types of
constraints and objectives that were also available in the clinical TPS. In principle this
could result in a sub-optimal wishlist, but we did not ¡nd any evidence for this.When
comparing the output of Erasmus-iCyclewith the ¡nalVMATauto plans, onlyminor dif-
ferences in achieved values for the two highest prioritized objectives were observed (see
Table 7.2).For the other objectives the achieved values o¥en showed a small deterioration.
Some changes could be expected due to dierences in the dose calculation algorithm,
and because a 23 static beam IMRT plan, used for pre-optimization, was converted in a
single arcVMAT plan inMonaco.No improvements in plan quality were observedwhen
allowing a dual arc VMAT delivery.
To evaluatewhether theVMATauto plans could be accuratelydelivered,weperformed
dose measurements at an Elekta Synergy linac (Elekta AB, Sweden) using a 2D array in
an Octavius phantom (PTW, Germany) for 6 study patients, 2 from each group. Using
reference criteria for gamma evaluation of 3% global and 3mm distance to agreement, a
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pass-rate of at least 95.7% was observed.We are convinced that Erasmus-iCycle can be
used as a pre-optimizer for other commercialTPS aswell. In addition to a list of obtained
values for constraints and objectives, also a Dicom RT-Dose ¡le can be exported from
Erasmus-iCycle to be fed into a TPS to derive clinically acceptable and deliverableVMAT
plans. Further research to assess the feasibility and accuracy of this approach will be
performed.
Recently,Wu et al. [65] published an automatedVMAT planning procedure for head-
and-neck cancer patients based on a database with IMRT plans and overlap volume his-
tograms. In terms of target coverage and sparing of organs-at-risk the generated VMAT
planswere comparable to the IMRT plans.A rather large databasewith previously treated
IMRT patientswas required as input to assure propermatching for a new patient. Zhang
et al. [47] described an algorithm for fully automated IMRT planning for lung cancer.
¥e planning objectives and constraintswere selected from an expert database according
to tumor size and location. In terms of tumor coverage and normal tissue sparing the
automatically generated plans were intended to be better than, or at least equivalent to,
those manually designed by dosimetrists.
¥is study focused ondevelopment and evaluation of amethod for automatedVMAT
plan generation for prostate cancer patients. Extension of this technique to other patient
categories is under investigation.
7.5 Conclusions
A system for fully automated VMAT plan generation for prostate cancer patients was
developed and evaluated, avoiding manual trial-and-error tweaking of plan parameters
by dosimetrists.¥e system has recently been implemented in our clinic to improve plan
quality and reduce workload.
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8.1 Introduction
¥is thesis focuses on automation of tasks in the preparation phase of a radiotherapy
treatment, resulting in equal, or preferentially higher, treatment quality with less human
interference. Due to technical limitations, tumor doses needed for high local control
rates can currently not always be delivered, and successful tumor eradication may be
accompanied by serious side eects. On the other hand, increased eciency and cost
reduction are getting of great importance to keep high quality healthcare available for all,
and even allow for improvements, e.g. by adaptive treatment approaches. In this thesis
we have demonstrated that automation of tasks may result in higher quality treatments
(including those based on adaptive re-planning), and lower costs.
8.2 Current application of autocontouring in radiotherapy
A¥er the clinical validation study for head-and-neck cancer patients in 2010 (chapter 2),
atlas-based autosegmentation (ABAS) has been used in our institution for all head-and-
neck cancer patients. Since then, ABAS has also been evaluated and implemented in
daily routine for other treatment sites. Currently, ABAS is an essential tool in our daily
clinical work¤ow. In 2013, about 2700 ABAS runs were performed (on a total of ∼4500
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newly treated patients with external beam radiotherapy) for new breast, head-and-neck,
thoracic, brain, cervical, and prostate cancer. For head-and-neck cancer,ABASwas used
for autocontouring of organs-at-risk (OARs) and elective neck targets. For the other
sites, autocontouring was limited to OARs. For another 800 patients, ABAS was used
for autosegmentation of a new scan based on a previously contoured CT-scan of the
same patient,whichwas then used as single atlas (‘intra-patient autosegmentation’ or ‘re-
contouring’). Re-scanning and re-contouring was frequently performed for head-and-
neck cancer patients that lost weight during treatment, requiring a new treatment plan.
In our clinical experience, for these patients, intra-patient autosegmentation resulted in
higher quality autocontours than the use of contoured scans of other, previously treated
patients as atlases. Only minor editing of autocontours was generally needed (∼15 min-
utes editing time). Intra-patient autosegmentation was also routinely applied for con-
touring of 4DCT scans of patients with tumors in the thoracic region. In these cases, the
treating physician ¡rst manually contoured a 3D scan belonging to a single respiratory
phase. Next, ABAS was used for propagating these manually delineated contours to the
other phases.
In literature, the use of autocontouring so¥ware for delineation of OARs and target
volumeshasbeendescribed for various treatment sites [e.g., 66–69]. In linewithour¡nd-
ings (chapters 2, 3, and clinical experience), careful evaluation of generated autocontours
and manual editing were recommended. Simmad et al. [69] tested two commercially
available atlas-based autosegmentation so¥ware tools for prostate cancer patients (ABAS,
Elekta, Sweden (also used in our studies), and iPlan RT Image, Brainlab, Germany). For
both systems, they concluded that editing of autocontours was mandatory for clinical
use. ¥ey also investigated the use of the contoured planning CT scan of a patient for
autocontouring of CBCTs acquired during treatment. ¥ey concluded that, due to the
poor CBCT image quality, the required accuracy for organ delineation and time savings,
needed for (online) adaptive radiotherapy, were not realized.
Despite the required inspection and editing of autocontours, substantial time sav-
ings have been reported compared to manual contouring, ranging from 26% [68]),
to 50% [69], or even 60% [67 and chapter 2 of this thesis].
¥e required accuracy of autocontours generally depends on the involved structures.
In chapter 3 we showed that editing of parallelOARs, like parotid glands, did not largely
aect the planned mean dose, o¥en being used for plan evaluation. Nevertheless, it is
to be expected that exact de¡nition of the boundaries of very small parallel OARs, like
submandibular glands, and swallowing muscles, is more critical. Also, accurate editing
of elective neck level CTVs turned out to be important in order to prevent large under-
dosages (chapter 3). Careful inspection, and possibly manual editing, of automatically
generated contours of serial organs, like the spinal cord, is also needed. Small inaccura-
cies in the de¡nition of the boundaries of these organsmay translate in large deviations in
Current clinical use and impact of Erasmus-iCycle | 103
ch
ap
te
r8
the percentage of volume treated to a high dose, and/or in the maximum dose delivered
to the organ.¥is eect is similar to the dosimetric consequenceswe observed for elective
neck level CTV contours in chapter 3.
In our studies for head-and-neck cancer patients described in chapters 2 and 3, and
in current clinical practice,we did not use the autocontouring so¥ware for delineation of
the primary tumor. First, the locations and shapes of the primary tumors do largely dier
betweenpatients.Consequently, it ishardlypossible tode¡ne a set of atlases to beused for
accurate autosegmentation of the primary tumor. Besides this, the CTV of the primary
tumor is generally based on more information than available in the planning CT only.
Physicians use patient speci¡c information obtained frommultiple imaging modalities,
which may be supplemented by surgical reports, or visual examinations.
In the evolving ¡eld of online-adaptive planning, accurate and fast autocontouring
is a prerequisite.An online-adaptive procedure should take a couple of minutes atmaxi-
mum. In this limited timeframe, the entirework¤ow should be ¡nalized: acquisition of a
newCT, (semi-) automated contouring of target volumes andOARs, and generation and
QA of thenew treatment plan. Li et al. [70] set up a clinical adaptivework¤ow for prostate
cancer patients treated with IMRT, using an in-room diagnostic CT.¥e structures de-
lineated on the initial planning CT scan were mapped to the second CT scan using
deformable image registration. For this purpose, a segmentation and registration toolkit
was incorporated in the treatment planning system (TPS).Compared tomanual prostate
contouring in daily scans, Dice coecients of 0.84 were obtained for autosegmentation.
To avoid the need for online manual reviewing and editing, while maintaining adequate
target coverage, they automatically expanded the prostate autocontours by 3 mm, prior
to automated generation of the plan-of-the-day.
8.3 Current clinical use and impact of Erasmus-iCycle
¥e ¡rst clinical application of Erasmus-iCycle was during our prospective head-and-
neck cancer study (Chapter 5). For the participating patients, the research optimization
algorithm, Erasmus-iCycle, was used to fully automatically generate a treatment plan,
which was then accurately reconstructed in the clinical TPS by one of the investigators,
resulting in a clinically deliverable plan, highly similar to the original Erasmus-iCycle
plan. Based on the observed strong preference of treating physicians for the recon-
structed Erasmus-iCycle treatment plans compared to fully manually generated plans,
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we implemented Erasmus-iCycle in our standard routine for plan generation for head-
and-neck cancer patients (in 2013: 450 plans for 300 patients). In the same period, some
initial tests were performed using Erasmus-iCycle for cervical cancer patients. Also for
this treatment site, Erasmus-iCycle proved to be useful as pre-optimization step, result-
ing in higher plan quality compared to manual planning from scratch. As from June
2011, Erasmus-iCycle is used for clinical plan generation for all cervical cancer patients
(31 patients treated in 2013). InNovember 2013,we implemented fully automatedVMAT
planning for prostate cancer patients, as described in chapter 7. For this application,
Erasmus-iCycle is still used as pre-optimization for generation of VMAT plans in the
clinical TPS, but we now realized a fully automated reconstruction of Erasmus-iCycle
plans in Monaco, avoiding manual plan reconstruction by dosimetrists as described in
chapter 5 for head-and-neck cancer patients. Till February 1st, 2014, 25 patients were
treated with this procedure. Erasmus-iCycle is currently also being used for linac-based
SBRT for liver.
From the studies described in this thesis and our clinical experiences so far, we have
concluded that semi-automated or fully automated plan generation, based on Erasmus-
iCycle pre-optimization, results in equal or better plan quality than obtained with the
commonmanual trial-and-error planning procedure. In all cases the planningworkload
is substantially reduced. In on-going projects, expansion of Erasmus-iCycle based plan-
ning toward new treatment sites is being prepared, and further use of fully automated
instead of semi-automated plan generation is being explored. In the meantime, a user-
friendly user interface has been developed to support broad clinical application.
8.4 Development of wishlists for Erasmus-iCycle plan
generation
Basic input for each Erasmus-iCycle plan generation is the wishlist in which clinical
objectives with assigned priorities and constraints are de¡ned. Wishlists are generated
for groups of patients with a similar treatment site and dose prescription. Each wishlist
fully de¡nes the automated plan generation for all patients in the group; no tweaking for
individual patients is performed.
¥e work¤ow for development of a wishlist for a new treatment site is brie¤y sum-
marized in Figure 8.1.¥e involved team consists of an expert dosimetrist or physicist
and a group of radiation oncologists, treating these speci¡c patients. In the ¡rst step, the
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generation of initial wishlist based
on review of recently delivered plans
Erasmus-iCycle plan generation for limited
set of patients based on current wishlist
update wishlist based on review
of generated plans
nal wishlist
Figure 8.1:WorkDow for generating awishlist.
planning expert and the physicians review plans of recently treated patients.¥e goal is
that the expert gets a clear view on applied hard constraints and treatment objectives,
including their priorities. In addition, the expert tries to ¡nd out what physicians like
and do not like in the current plans, what they would like to improve if they had the
possibility, what their ideas are on the balance betweenOAR sparing and dose fall-o in
unspeci¡ed tissues, etc. Based on this input, the initialwishlist is generated by the expert,
and then further optimized in an iterative procedure (Figure 8.1). In this procedure, the
wishlist is repeatedly updated based on Erasmus-iCycle plan generationwith the current
wishlist for a group of ∼5 patients, followed by plan review (depending on the iteration
with orwithout physicians). Initially, the focus is on obtaining clinically acceptable plans,
while later iterations are focusedon improvements compared to current clinicalplan gen-
eration. At some point in the iterative procedure, the initially involved ∼5 patients used
for development of the wishlist, are substituted by ∼5 new patients for an independent
evaluation of the wishlist.
Clinical implementation of fully automated VMAT planning as described in chap-
ter 7 included a ¡nal test of the quality of the wishlist, generated with the procedure
described above. For the ¡rst 10 clinical patients, dosimetrists were asked to manually
tweak the prescription parameters in theMonaco plan to investigatewhether they could
improve on the quality of the automatically generated plan.Only small improvements in
rectumV75 Gy (up to 0.8%) could be achieved at the cost of unfavorable dose increases in
lower prioritized OARs and/or in a deteriorated dose fall-o in the unspeci¡ed tissues.
When starting automated planning for a new treatment site, such a QA procedure is
highly recommended for the ¡rst patients. Involvement of clinicians, dosimetrists and
physicists that were not involved in establishment of the wishlist allows for an indepen-
dent, complimentary check on plan quality.
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8.5 (Possible) limitations of Erasmus-iCycle and future work
Pareto navigation and clinical optimality
¥e 2pεc multicriterial optimizer in Erasmus-iCycle generates for each patient a single
Pareto-optimal plan for the ¡nal selected beam con¡guration, the so-called wishplan.
For every patient, the wishlist, as established for the patient group, is the driving force
for generation of this particular wishplan, instead of another Pareto-optimal solution.
In our experience, the wishplans have very high quality compared to manual planning,
and there are no indications that plans with (substantially) improved quality do exist.
On the other hand,we did not systematically investigate this for large groups of patients:
neither do we currently have tools available to carefully perform these investigations. To
allow this type of analyses, we are currently extending Erasmus-iCycle with a sensitivity
analysis tool, i.e. a Pareto-navigation tool, like described byMonz et al. [71] and¥ieke et
al. [43]. For future research, we intend to use the wishplan generated by Erasmus-iCycle
as starting point for navigation, since we believe that this plan is already of good quality.
One of the research objectives is to ¡nd out whether Pareto navigation can be limited to
an area close to the wishplan.
Faster alternative for the current 2pεc optimizer in Erasmus-iCycle
Currently, the 2pεc algorithm is used for stepwise optimization of individual objectives
in the wishlist according to their priorities. For more complex cases like in head-and-
neck cancer, a wishlist may consist of more than 20 objectives, requiring a large num-
ber (>20) of consecutive optimizations in Erasmus-iCycle. In Erasmus-iCycle, the typ-
ical clinical optimization time in Erasmus-iCycle for a plan with 23 ¡xed equiangular
beams, as used in the pre-optimization phase of automated prostate VMAT planning
(chapter 7), is 35 minutes. Optimization of treatment plans for head-and-neck cancer
patients, including beam angle optimization, takes about 1 hour for 9 coplanar beams,
and up to 12 hours for 9 noncoplanar beams (both techniques using BAO). Recently,
we have evaluated the lexicographic reference pointmethod (LRPM) [72] as alternative
for the 2pεc algorithm.¥e main advantage of LRPM is that it requires only one single
optimization, even for a largewishlist. By adding lexicographic ordering of the objectives
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based on the assignedpriorities in thewishlist,prioritized optimizationwas retainedwith
LRPM, like in the 2pεc method. Application of LRPM was tested retrospectively for the
30 prostate cancer patients used in chapter 7. Dierences in obtained plan parameters
compared to 2pεc optimization were neither clinically, nor statistically, signi¡cant.With
LRPM, optimization times reduced by a factor of nearly 12 (from 34.9 to 3.0minutes on
average). Currently, we are further evaluating the application of LRPM.
8.6 Changing role of dosimetrists
For several treatment siteswe have demonstrated that automated plan generation results
in a consistent, high plan quality. It is expected that this will hold for most treatment
sites. Large scale clinical introduction will result in important shi¥s in the activities of
dosimetrists.¥ey will get responsibilities for generating and tuning wishlists for di-
cult, non-standard patients, and for adapting existing wishlists when clinical treatment
protocols aremodi¡ed.Overall, for a ¡xed patient load, the required planningmanpower
will reduce. ¥is does not mean that the need for highly quali¡ed technicians (o¥en
(partly) working as dosimetrists in ¥e Netherlands) will reduce. Instead of treatment
planning, they will have to play an important role in the development and execution
of complex novel treatment techniques such as adaptive radiotherapy. Recently, Bondar
et al. [73] presented an online-adaptive IMRT technique for cervical cancer patients,
based on a pretreatment established individualized plan library, generated with variable
bladder ¡llingCT scans. Since the beginning of the clinical implementation, in June 2011,
85 patients have been treated according to this protocol.¥e technicians at the linac now
have to select in each fraction the most suitable plan, based on in-room imaging. Ulti-
mately, for real-time online-adaptive treatment, a plan-of-the-day treatment will consist
of daily acquisitionof an in room (cone beam)CT orMR, real-time online re-contouring,
re-planning, and plan evaluation and QA, which should all take place in a time-frame
of several minutes. Highly trained technicians are indispensable for safe and eective
application of such protocols.
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8.7 Conclusion
In this thesis we have described some major advantages of automatic contouring and
treatment planning. In the coming years, the interest and clinical application of these
techniques are expected to grow extensively. Important new applications are expected
in the upcoming ¡eld of dose-adaptive radiotherapy, which might be applied on a daily
base.
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summary
¥is thesis focuses on the automation of tasks in the preparation phase of a radiotherapy
treatment, resulting in equal, or preferentially higher, treatment quality with less human
interference. Chapter 1 is a general introduction into radiotherapy treatment, and gives
a short description of the performed research projects. Chapter 2 describes a clinical
validation study of atlas-based autosegmentation (ABAS) for head- and-neck cancer pa-
tients. In chapter 3, we address the question if it is necessary to review and edit structure
sets generated by autocontouring so¥ware before using them for treatment planning.
Chapter 4 describes the use of Erasmus-iCycle for an objective investigation on the im-
pact of integrated, computerized optimization of beam orientations and IMRT ¤uence
pro¡les on salivary gland sparing in head-and-neck cancer patients. Based on the results
of this work, we performed a randomized, prospective clinical study comparing auto-
matically and manually generated intensity modulated radiotherapy treatment (IMRT)
plans for head-and-neck cancer patients. Chapter 5 summarizes the results of this study.
In chapter 6 we compare dierent IMRT planning strategies for prostate cancer patients
with metal hip prostheses using Erasmus-iCycle. Chapter 7 describes fully automated
volumetric modulated arc therapy (VMAT) plan generation for prostate cancer patients.
Chapter 8 is a general discussion related to the main topics described in this thesis and
describes some directions for further research.
Chapter 2
We performed a clinical validation study on ABAS for delineation of multiple clinical
target volumes and normal tissue structures for head-and-neck cancer patients. Two dif-
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ferent ABAS strategies, using either a single atlas or atlases frommultiple subjects, were
evaluated.Using the leave-one-outmethod, the similarity of the generated autocontours
and the (input) atlas contourswas assessed usingDice coecients andmean distances to
agreement. For 12 clinically treated patients, 5 experienced observers edited the autoseg-
mented contours.¥e editing timeswere recorded.Dice coecients andmean distances
were calculated among clinically used contours, autocontours and edited autocontours.
Finally, an expert panel scored all autocontours and the edited autocontours regarding
their adequacy relative to the published atlas.
ABAS needed 7minutes per patient to autosegment all structures.Dierences in the
autosegmentation accuracy were not signi¡cantly dierent betweenN0 andN+ patients.
¥e multi-subject atlas performed best, yielding a Dice coecient and mean distance of
0.74 and 2 mm for salivary glands, 0.67 and 3 mm for neck levels, 0.71 and 2 mm for
chewing muscles, 0.50 and 2 mm for swallowing muscles, and 0.78 and 2 mm for the
cord and brainstem. For the neck levels and salivary glands the mean Dice coecient
and the mean distance between the autocontours and clinically applied contourswas 0.8
and 2.4 mm, respectively. Between the autocontours and the edited autocontours, those
values were 0.9 and 1.6 mm, respectively. ¥e expert panel scored all autocontours as
“minor deviation, editable” or better. 88% of the edited contours were scored as “good”
opposed to 83% for the clinically used contours.
Multiple-subject ABAS of CT images proved to be a useful novel tool for fast delin-
eation of targets and normal tissues. Although editing of the autocontours turned out
to be inevitable, a substantial time reduction was achieved when compared to manual
contouring from scratch (66 versus 180min).
Chapter 3
In this study, the dosimetric impact of editing autocontours of elective neck CTVs and
organs-at-risk (OARs), generated by ABAS, was investigated for head-and-neck cancer
patients. For nine patients, structure sets generated by ABAS and edited autocontours
by two observers were available. Based on the non-edited autocontours clinically ac-
ceptable IMRT plans (designated ‘ABAS plans’) were generated.¥ese plans were then
evaluated for the two edited structure sets.Dice coecients and mean contour distances
were calculated to quantify the similarity of ABAS autocontours and the structure sets
edited by observer 1 and observer 2. To study the dosimetric importance of editingOAR
autocontours a new IMRT plan was generated for each patient-observer combination,
based on theCTV edited by the observer and thenon-edited salivary gland autocontours.
For each plan, mean doses for the non-edited and edited glands were compared.
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For both observers, edited neck CTVs were larger than ABAS autocontours, by 8.7%
on average (p ≤ 0.04).When evaluating ABAS plans on the PTVs of the edited structure
sets, V95% reduced by 7.2% ± 5.4% (1 SD) (p < 0.03). ¥e mean reduction in D99% was
14.2 Gy (range 1–54 Gy). Even for Dice coecients >0.8 and mean contour distances<1 mm, reductions in D99% up to 11 Gy were observed. For treatment plans based on
observer PTVs and non-edited autocontoured salivary glands, the mean doses in the
edited glands diered by only -0.6 Gy ± 1.0 Gy (p = 0.06).
¥is shows that editing of autocontoured neck CTVs generated by ABAS is required
to avoid large underdosage in target volumes. O¥en used similarity measures for eval-
uation of autocontouring algorithms, such as Dice coecients, do not predict well for
expected PTV underdose. Editing of salivary glands is less important, as mean doses
achieved for non-edited glands predict well for edited structures.
Chapter 4
In this study, we quanti¡ed improved salivary gland sparing for head-and-neck cancer
patientswhenusing IMRT plans based on integrated computerized optimization of beam
orientations and intensity pro¡les.¥e eect on plan quality using optimized non-zero
couch angles in VMAT plans was assessed as well. Erasmus-iCycle was used for auto-
mated generation of multicriterial optimized plans with optimized beam orientations
and intensity pro¡les, and plans with optimized pro¡les for preselected beam arrange-
ments. For 20 patients, 5 IMRT plans, based on one ‘wishlist’, were compared: i), ii)
seven- and nine-beam equiangular coplanar plans (iCycle7equi, iCycle9equi), iii), iv) nine-
beam plans with optimized coplanar and noncoplanar beam orientations (iCyclecopl,
iCyclenoncopl) and v) a nine-beam coplanar plan with optimized gantry angles and one
optimized couch rotation (iCyclecouch). VMAT plans without and with this optimized
couch rotation were evaluated.
Erasmus-iCycle allowed objective comparison of the dierent planning strategies.
iCyclenoncopl resulted in the best salivary gland sparing, but iCyclecouch yielded similar
results for 18 patients. For iCycle7equi, submandibular gland NTCP values were on av-
erage 5% higher. iCycle9equi performed better than iCycle7equi. iCyclecopl showed further
improvement, indicating the bene¡t of integrated optimization of beam angles and beam
pro¡les.Application of the optimized couch angle from iCyclecouch also improvedNTCP
values in VMAT plans.
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Chapter 5
In this prospective clinical study, we made a comparison of plans generated with
Erasmus-iCycle and plansmanually generated by dosimetristswith the clinical treatment
planning system. For 20 randomly selected head-and-neck cancer patients with various
tumor locations (of whom 13 received sequential boost treatments) we oered the treat-
ing physician the choice between an automatically generated Erasmus-iCycle plan and
a manually optimized plan using standard clinical procedures. While Erasmus-iCycle
used a ¡xed ‘wishlist’ with hard constraints and prioritized objectives, the dosimetrists
manually selected the beam con¡guration and ¡ne-tuned the constraints and objectives
for each IMRT plan.Dosimetrists and treating physicians were not informed in advance
whether a competing Erasmus-iCycle planwasmade.¥e two planswere simultaneously
presented to the physician, who then selected the preferred plan to be used for patient
treatment. For the patient group, we also quanti¡ed dierences in PTV coverage and
sparing of critical tissues.
In 32/33 plan comparisons the physician selected the Erasmus-iCycle plan for treat-
ment. ¥is highly consistent preference for automatically generated plans was mainly
caused by improved sparing for the large majority of critical structures.With Erasmus-
iCycle, the normal tissue complication probabilities (NTCPs) for parotid and sub-
mandibular glands were reduced by 2.4% ± 4.9% (maximum: 18.5%, p = 0.001) and
6.5% ± 8.3% (maximum: 27%, p = 0.005), respectively.¥e reduction in mean oral cav-
ity dose was 2.8 Gy ± 2.8 Gy (maximum: 8.1 Gy, p = 0.005). For swallowing muscles,
esophagus and larynx, the mean dose reduction was 3.3 Gy ± 1.1 Gy (maximum: 9.2 Gy,
p < 0.001). In addition, for 15 of the 20 patients, the target coveragewas improved aswell.
Apart from improved plan quality, automatic plan generation is economically attractive
because of reduced workload.
Chapter 6
In this study, dierent IMRT planning strategies for prostate cancer patients with metal
hip prostheseswere compared.All planswere generated fully automatically (i.e.,without
human trial-and-error interactions) using Erasmus-iCycle, allowing objective compari-
son of planning strategies. For 18 prostate cancer patients (8with bilateral hip prostheses,
10 with a right-sided unilateral prosthesis), two planning strategieswere evaluated: i) full
exclusion of beams containing beamlets thatwould deliver dose to the target a¥er passing
a prosthesis (IMRTremove), and ii) exclusion of those beamlets only (IMRTcut). Planswith
optimized coplanar and noncoplanar beam arrangementswere generated.Dierences in
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PTV coverage and sparing of OARs were quanti¡ed. ¥e impact of beam number on
plan quality was evaluated.
Especially for patients with bilateral hip prostheses, IMRTcut signi¡cantly improved
rectum and bladder sparing compared to IMRTremove. For 9-beam coplanar plans, rec-
tum V60 Gy reduced by 17.5% ± 15.0% (maximum 37.4%, p = 0.036) and rectum Dmean
by 9.4% ± 7.8% (maximum 19.8%, p = 0.036). Further improvements in OAR sparing
were achievable by using noncoplanar beam set-ups, reducing rectumV60 Gy by another
4.6% ± 4.9% (p = 0.012) for noncoplanar 9-beam IMRTcut plans. Large reductions in
rectumdose deliverywere also observedwhen increasing the number of optimized beam
directions in the plans. For bilateral implants, the rectum V60 Gy was 37.3% ± 12.1% for
coplanar 7-beam plans and reduced on average by 13.5% (maximum 30.1%, p = 0.012) for
15-beam plans.
Erasmus-iCycle was able to automatically generate high quality plans for prostate
cancer patients with metal hip prostheses. Excluding only beamlets that passed through
the prostheses (IMRTcut strategy) signi¡cantly improved OAR sparing. Noncoplanar
beam arrangements and, to a larger extent, increasing the number of treatment beams,
further improved plan quality.
Chapter 7
A system for fully automatedVMAT treatment planning for prostate cancer patientswas
developed, evaluated, and clinically implemented. Erasmus-iCycle was directly linked
with our clinical, commercially available TPS to fully automatically generate VMAT
plans (VMATauto). For 30 randomly selected patients, VMATauto plans were compared
with VMAT plans generated manually by one expert dosimetrist in the absence of time
pressure (VMATman). For all treatment plans, PTV coverage and sparing of OARs were
quanti¡ed.
All generated plans were clinically acceptable and had similar PTV coverage (V95%> 99%). For VMATauto and VMATman plans the OAR sparing was similar as well, while
only the former plans were generated without any manual planning workload. For the
¡rst ten clinically treated patients, dosimetrists were asked to attempt improving the
VMATauto plans bymanually tweaking the plan objectives inMonaco in a trial-and-error
procedure, as normally done in clinical practice. Rectum V75 Gy an rectum V60 Gy were
on average slightly lower in the tweaked plans (maximum dierence 1%), but thisminor
improvement in rectum parameters generally resulted in an increased dose delivery to
the other, lower prioritized OARs and/or in a deteriorated dose fall-o in unspeci¡ed
tissues.
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¥e results of this study clearly show that fully automated generation of high quality
VMAT plans for prostate cancer patients is feasible.¥e procedure is currently routinely
applied in our clinic.
Chapter 8
¥is chapter presents a general discussion on the main research topics in this thesis.
Current clinical applications of automated contouring and treatment planning are sum-
marized. Amongst others, topics for further research are related to speeding up both
procedures, evaluating them for new treatment sites and making them more widely ap-
plicable.
samenvatting
Het onderzoek dat in dit proefschri¥wordt beschreven hee¥ betrekking op de automati-
sering van verschillende taken in het voorbereidingstraject van een radiotherapie behan-
deling, met als doel om een gelijke, of bij voorkeur betere, kwaliteit van behandeling te
verkrijgenmetminder handmatige handelingen.Hoofdstuk 1 is een algemene introduc-
tie in de radiotherapie, en gee¥ een korte beschrijving van de uitgevoerde onderzoeks-
projecten. Hoofdstuk 2 beschrij¥ de resultaten van een klinische validatiestudie van het
gebruik van op atlassen gebaseerde (atlas-based) autosegmentatie so¥ware (ABAS) voor
hoofd-hals kankerpatie¨nten. In hoofdstuk 3 beantwoorden we de vraag in hoeverre het
noodzakelijk is omdemet deze so¥ware automatisch ingetekende structuren te controle-
ren en aan tepassen voordatdezeworden gebruikt voorhetmaken van een behandelplan.
Hoofdstuk 4 onderzoekt, gebruik makend van Erasmus-iCycle, in hoeverre afname in de
speekselklierfunctie bij hoofd-hals kankerpatie¨nten kan worden beperkt door behalve
de intensiteitgemoduleerde ¤uentiepro¡elen van de behandelbundels ook de bundel-
orie¨ntaties automatisch te optimaliseren. Gebaseerd op de resultaten van deze studie
hebben we een gerandomiseerde prospectieve klinische studie uitgevoerd voor hoofd-
hals patie¨nten waarin we automatisch gegenereerde intensiteitgemoduleerde radiothe-
rapie (IMRT) behandelplannen hebben vergeleken met handmatig gemaakte plannen.
De resultaten van deze studie zijn samengevat in hoofdstuk 5. In hoofdstuk 6 vergelijken
we verschillende IMRT planningstrategiee¨n voor prostaatkankerpatie¨nten met metalen
heupprothesen, gebruikmakend van Erasmus-iCycle.Hoofdstuk 7 beschrij¥ een volledig
automatische procedure om volumetrisch gemoduleerde rotatietherapie (VMAT) plan-
nen te maken voor prostaatkankerpatie¨nten.Hoofdstuk 8 is een algemene discussie over
de onderwerpen in dit proefschri¥, en beschrij¥ richtingen voor toekomstig onderzoek.
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Hoofdstuk 2
We hebben een klinische validatiestudie uitgevoerd om te bepalen in hoeverremetABAS
klinische doelvolumina en gezonde weefselstructuren voor hoofd-hals patie¨nten nauw-
keurig en snel kunnen worden ingetekend.We hebben daarbij twee verschillende ABAS
strategiee¨n gee¨valueerd, gebruikmakend van een enkele atlas en gebruikmakend van at-
lassen vanmeerdere patie¨nten. Gebruik makend van de leave-one-out methode werd de
overeenkomst tussen een gegenereerde autocontour en een (input) atlascontour gekwan-
ti¡ceerd door de Dice coe¨cie¨nt en de gemiddelde afstand tussen beide contouren te
bepalen. Voor 12 klinisch behandelde patie¨nten hebben 5 ervaren artsen de automatisch
gegenereerde contouren gecontroleerd en desgewenst handmatig aangepast. De tijd die
ze daarvoor per patie¨nt nodig hadden is bijgehouden. Dice coe¨cie¨nten en gemiddelde
afstanden zijn berekend tussen de klinisch gebruikte contouren, de automatisch gege-
nereerde contouren (autocontouren), en de aangepaste autocontouren. Tenslotte is door
een expert panel de nauwkeurigheid van enerzijds de autocontouren en anderzijds de
handmatig aangepaste autocontouren beoordeeld in vergelijking met een gepubliceerde
atlas.
Per patie¨nt had ABAS 7 minuten nodig om alle structuren te segmenteren. Er was
geen signi¡cant verschil in de nauwkeurigheid van de segmentatie voor patie¨nten met
en zonder positieve halsklieren. De nauwkeurigheid van autosegmentatie was het beste
wanneer gebruik gemaakt werd van atlassen van meerdere patie¨nten. Hierbij was de
gemiddeldeDice coe¨cie¨nt en de gemiddelde afstand tussen autocontouren en de input
data 0,74 en 2mm voor de speekselklieren, 0,67 en 3mm voor de verschillende halsklier
niveaus, 0,71 en 2 mm voor de kauwspieren, 0,50 en 2 mm voor de slikspieren, en 0,78
en 2 mm voor het ruggenmerg en de hersenstam. De gemiddelde Dice coe¨cie¨nt en
de gemiddelde afstand van de autocontouren ten opzichte van de klinisch gebruikte
contouren was 0,8 en 2,4 mm voor de halsklier niveaus en de speekselklieren.Wanneer
de autocontouren werden vergeleken met de handmatig aangepaste autocontouren was
de gemiddelde Dice coe¨cie¨nt 0,9 en de gemiddelde afstand 1,6 mm. Het expert panel
scoorde alle autocontouren als “weinig afwijkend, goed aan te passen” of beter. 88% van
de aangepaste autocontouren werd gescoord als “goed”, ten opzichte van 83% voor de
klinisch gebruikte contouren.
Uit deze studie blijkt dat ABAS zeer goed bruikbaar is om doelvolumina en ge-
zonde weefsels snel en automatisch in te laten tekenen wanneer gebruik gemaakt wordt
van atlassen vanmeerdere patie¨nten. Hoewel de autocontourenmeestal nog handmatig
moesten worden aangepast, was hiervoor veel minder tijd nodig dan wanneer de con-
touren volledig handmatig werden ingetekend (66 in plaats van 180minuten).
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Hoofdstuk 3
In deze studie hebben we het dosimetrische eect onderzocht van het aanpassen van
autocontouren voor electief te bestralen halsklieren (CTVs) en risico-organen die met
ABAS werden ingetekend bij hoofd-hals patie¨nten. Voor 9 patie¨nten waren datasetsmet
ABAS autocontouren en door twee artsen aangepaste autocontouren beschikbaar. Ge-
baseerd op de niet-aangepaste autocontouren zijn klinisch acceptabele IMRT plannen
gemaakt (ABAS-plannen genaamd). Deze plannen zijn vervolgens gee¨valueerd voor de
twee aangepaste contour sets.Dice coe¨cie¨nten en gemiddelde afstanden zijn berekend
om de overeenkomst tussen ABAS autocontouren en de door de artsen aangepaste con-
toursets te bepalen. Om het dosimetrische eect van het aanpassen van autocontou-
ren voor risico-organen te bepalen werd een nieuw IMRT plan gegenereerd, gebaseerd
op de door de artsen aangepaste CTVs en de niet aangepaste autocontouren voor de
speekselklieren. Voor ieder plan is de gemiddelde dosis van de automatisch ingetekende
speekselklieren vergeleken met de gemiddelde dosis van de door een arts aangepaste
intekening van speekselklieren.
Voor beide artsen waren de aangepaste CTVs groter dan de ABAS autocontour, met
een gemiddelde van 8,7% (p ≤ 0,04) Wanneer we de ABAS plannen evalueerden op
het te bestralen doelvolume (PTV) voor de aangepaste contour sets, nam het volume
dat bestraald werd tot 95% van de voorgeschreven dosis (V95%) af met 7,2% ± 5,4%
(1 SD) (p < 0,03). De gemiddelde afname in de minimale dosis in 99% van het volume
(D99%) was 14,2 Gy (bereik 1–54 Gy). Zelfs voor Dice coe¨cie¨nten >0,8 en gemiddelde
afstanden tussen contouren <1 mm, kwamen reducties in D99% tot 11 Gy voor. Voor de
behandelplannen gebaseerd op de PTVs die door de artsen waren gede¡nieerd en de
niet-aangepaste, automatisch ingetekende speekselklieren was de gemiddelde dosis in
de aangepaste speekselklieren slechts 0,6 Gy ± 1,0 Gy (p = 0,06) lager.
Dit laat zien dat het aanpassen van autocontouren van halsCTVs die doorABAS zijn
gegenereerd noodzakelijk is omgrote onderdosering in doelvolumina voor de bestraling
te voorkomen. Veelgebruikte maten voor de overeenkomst tussen volumina, zoals de
Dice coe¨cie¨nt, hebben geen voorspellende waarde voor de te verwachten onderdose-
ringen in het PTV.Het aanpassen van de intekening van de speekselklieren bleekminder
belangrijk omdat het verschil in gemiddelde dosis voor de automatisch ingetekende en
de aangepaste klieren gering is.
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Hoofdstuk 4
In deze studie hebben we onderzocht in hoeverre de afname van de speekselklierfunctie
tijdens bestraling van hoofd-hals patie¨nten kan worden beperkt, door gebruik te maken
van IMRT plannen waarbij, behalve de intensiteitspro¡elen, ook de bundelhoeken van
de bestralingsvelden automatisch worden geoptimaliseerd. Daarnaast is onderzocht of
VMAT plannen kunnen worden verbeterd door gebruik te maken van een geoptimali-
seerde tafeldraaiing. We hebben Erasmus-iCycle gebruikt voor het automatisch gene-
reren van multicriteria IMRT plannen met geoptimaliseerde bundelhoeken en inten-
siteitspro¡elen, en van plannen met geoptimaliseerde intensiteitspro¡elen maar vooraf
vastgelegde bundelhoeken.Voor 20 patie¨nten werden 5 IMRT plannen vergeleken geba-
seerd op e´e´n identiekewishlist: i), ii) plannenmet zeven ennegen equidistante coplanaire
bundels (iCycle7equi, iCycle9equi), iii), iv) negen bundel plannenmet geoptimaliseerde co-
planaire en niet-coplanaire bundelhoeken (iCyclecopl, iCyclenoncopl) en v) een coplanair
negen bundelplan met geoptimaliseerde bundelhoeken en e´e´n geoptimaliseerde tafel-
hoek (iCyclecouch). VMAT plannenmet en zonder deze geoptimaliseerde tafelhoek zijn
gee¨valueerd.
Door gebruik te maken van Erasmus-iCycle zijn we in staat om de verschillende
planningstrategiee¨n op een objectieve manier te vergelijken. iCyclenoncopl resulteerde in
de laagste dosis in de speekselklieren, maar iCyclecouch liet vergelijkbare resultaten zien
voor 18 patie¨nten. Het voorspelde risico op bijwerkingen (NTCP) voor de submandi-
bulaire speekselklieren was gemiddeld 5% hoger voor iCycle7equi. iCycle9equi deed het
beter dan iCycle7equi en iCyclecopl liet een verdere verbetering zien. Het toepassen van
de geoptimaliseerde tafeldraaiing verbeterde ook de NTCP waardes in VMAT plannen.
Hoofdstuk 5
In deze prospectieve klinische studie hebben we plannen die automatisch met Erasmus-
iCyclewerden gegeneerd en handmatig gegeneerde plannenmet het klinische planning-
systeem vergeleken.Voor 20willekeurig geselecteerde hoofd-hals patie¨ntenmet verschil-
lende tumorlocaties (waarvan 13 een sequentie¨le boostbehandeling kregen) hebben we
de behandelend arts laten kiezen tussen een automatisch gegenereerd Erasmus-iCycle
plan en een handmatig geoptimaliseerd plan volgens de standaard klinische procedures.
Erasmus-iCyclemaakte gebruik van een vaste ‘wishlist’ bestaande uit harde voorwaarden
en geprioriteerde doelen voor het uiteindelijke behandelplan. De laboranten daarente-
gen kozen de bundelhoeken, en optimaliseerden de voorwaarden en doelen handmatig
voor iedere IMRT planning.Noch de laborant, noch de behandelend artswerden vooraf
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ge¨ınformeerd of er een concurrerendErasmus-iCycle plan gemaakt zouworden.De twee
plannen werden gelijktijdig aan de arts getoond, waarna deze e´e´n van beide plannen
selecteerde voor patie¨ntbehandeling. Voor de patie¨ntgroep hebben we het verschil in de
minimale dosisdekking van het PTV en in de afgegeven dosis in risico-organen bepaald.
In 32/33 planningen selecteerde de arts het Erasmus-iCycle plan voor behandeling.
Deze zeer consistente voorkeur voor de automatisch gegenereerde plannenwerd in hoge
mate ingegeven door een lagere dosisafgi¥e in een groot aantal risico-organen. Zo werd
met Erasmus-iCycle het voorspelde risico op bijwerkingen voor de grote en kleine speek-
selklieren verminderd met respectievelijk 2,4% ± 4,9% (maximum: 18,5%, p = 0,001)
en 6,5% ± 8,3% (maximum: 27%, p = 0,005). De dosisreductie in de mondholte was
2,8 Gy ± 2,8 Gy (maximum: 8,1 Gy, p = 0,005). Voor slikspieren, de slokdarm en het
strottenhoofd was de afname in gemiddelde dosis 3,3 Gy ± 1,1 Gy (maximum: 9,2 Gy,
p < 0,001).Daarnaastwas voor 15 van de 20 patie¨nten de minimale dosisdekking van het
PTV verbeterd. Behalve dat door het automatisch genereren van plannen de plankwali-
teit verbetert, is dit ook economisch aantrekkelijk doordat dewerklast voor planningsla-
boranten afneemt.
Hoofdstuk 6
In deze studie werden verschillende IMRT strategiee¨n vergeleken voor prostaatkanker-
patie¨ntenmetmetalen heupprothesen. Alle plannen werden volledig automatisch gege-
nereerd met Erasmus-iCycle, dus zonder handmatige interacties, zodat een objectieve
planvergelijking mogelijk was. Er werden plannen met geoptimaliseerde coplanaire en
niet-coplanaire bundelhoeken gemaakt. Voor 18 prostaatkankerpatie¨nten (8 met twee-
zijdige heupprothesen, 10 met een enkelzijdige, rechterprothese) zijn er twee planning-
strategiee¨n gee¨valueerd. In de eerste strategiewerden bundelrichtingen vanwaaruit dosis
in een prothese werd afgegeven voordat het doelvolume werd bereikt niet geselecteerd
(IMRTremove). In de tweede strategie mochten deze bundelrichtingen wel worden ge-
selecteerd, en werd alleen het deel van de bundel afgedekt dat directe dosis aan het
doelvolume zou afgeven nadat het door de prothese is gegaan (IMRTcut). Verschillen
in de minimale dosisdekking van het PTV en de dosisafgi¥e in risico-organen werden
gekwanti¡ceerd.
Voor patie¨nten met tweezijdige heupprothesen was er een signi¡cante verlaging te
zien in de afgegeven dosis in het rectum en de blaas wanneer IMRTcut werd gebruikt in
plaats van IMRTremove. Voor 9-bundel coplanaire plannen reduceerde het volume van
het rectum dat tot 60 Gy werd bestraald (V60 Gy) met 17,5% ± 15,0% (maximum 37,4%,
p = 0,036) en de gemiddelde rectumdosismet 9,4% ± 7,8% (maximum 19,8%, p = 0,036).
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Een verdere verlaging van dosis in de risico-organenwas haalbaar door gebruik temaken
van niet-coplanaire bundelcon¡guraties. Dit resulteerde voor niet-coplanaire 9-bundel
IMRTcut plannen tot een extra afname in V60 Gy met 4,6% ± 4,9% (p = 0,012). Een grote
dosisafname in het rectum werd ook gezien wanneer het aantal geoptimaliseerde bun-
delrichtingen in de planningen werd vergroot. Voor patie¨nten met dubbelzijdige heup-
prothesen was de rectum V60 Gy 37,3% ± 12,1% voor coplanaire 7-bundel plannen; voor
plannenmet 15 bundels reduceerde dit gemiddeldmet 13,5% (maximum 30,1%, p= 0,012).
Deze studie hee¥ aangetoond dat we met Erasmus-iCycle automatisch plannen van
hoge kwaliteit kunnen maken voor prostaatkankerpatie¨nten met heupprothesen. Door
alleen het deel van de bundel af te dekken dat eerst directe dosis afgee¥ in de heup-
prothese (IMRTcut strategie) wordt een signi¡cante afname in de dosisafgi¥e in risico-
organen bereikt.Het gebruik van niet-coplanaire bundelrichtingen en in hogeremate het
vergroten van het aantal bundelrichtingen gaf een verdere verbetering van de plankwa-
liteit.
Hoofdstuk 7
In dit onderzoek is een systeem voor het automatisch genereren van VMAT behan-
delplannen voor prostaatkankerpatie¨nten ontwikkeld, gee¨valueerd, en klinisch ge¨ımple-
menteerd.We hebben Erasmus-iCycle direct gekoppeld aan het in onze kliniek gebruikte
commercie¨le dosisplanningsysteem om volledig automatisch VMAT plannen te kun-
nenmaken (VMATauto).Voor 30 willekeurig geselecteerde patie¨nten werdenVMATauto
plannen vergelekenmet plannen die handmatig, zonder tijdsdruk, door e´e´n expertlabo-
rant gemaakt zijn (VMATman). Voor alle plannen werd de minimale dosisdekking van
het PTV en de dosisafgi¥e in risico-organen gekwanti¡ceerd.
Alle gegenereerde plannen waren klinisch acceptabel en hadden een vergelijkbare
minimale dosisdekking van PTV (V95% > 99%). De dosis in de risico-organen was ver-
gelijkbaar voorVMATauto enVMATman plannen, maar de eerstgenoemden werden ver-
vaardigd zonder enige werklast voor de laboranten. Voor de eerste 10 klinisch behan-
delde patie¨nten is aan laboranten gevraagd om te pogen om de VMATauto plannen te
verbeteren door handmatig, via een trial-and-error methode, te sleutelen aan de plan-
ningsdoelen in Monaco, zoals nu nog gebruikelijk is in de klinische praktijk. In deze
handmatig aangepaste plannen waren de rectum V75 Gy en de rectum V60 Gy gemiddeld
iets lager (maximaal verschil 1%), maar deze beperkte verbetering in de dosisafgi¥e in het
rectum resulteerde meestal in een toename van de dosis in andere, lager geprioriteerde
risico-organen en/of een verslechterde dosisafval in de omliggende weefsels.
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De resultaten van deze studie laten zien dat het volledig automatisch genereren van
VMAT plannen van hoge kwaliteit haalbaar is voor prostaatkankerpatie¨nten.Dezewerk-
wijze wordt nu standaard toegepast in onze kliniek.
Hoofdstuk 8
Dit hoofdstuk gee¥ een algemene discussie over de onderzoeksonderwerpen die in dit
proefschri¥ gepresenteerd zijn.De huidige toepassingen van het automatisch genereren
van contouren en plannen in onze kliniekworden beschreven.Toekomstig onderzoek zal
zich ondermeer richten op het sneller en breder toepasbaarmaken van beide procedures
en op de evaluatie van deze methodes voor nieuwe behandelingen.
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For automated contouring we have evaluated a commercially available 
atlas-based autosegmentation tool. With this tool, the CT-scan of a new patient 
can be segmented based on segmented scans of previously treated patients, 
called atlases, thereby signicantly reducing the manual contouring time.
For automated plan generation we have investigated Erasmus-iCycle, an in-house 
developed algorithm for multicriterial beam angle and prole optimization. For 
individual patients, Erasmus-iCycle can fully automatically generate Pareto-optimal 
plans, based on a wish-list with constraints and prioritized objectives specied for 
the corresponding disease / tumor site. Compared to manually generated plans, 
Erasmus-iCycle plans are superior or equal in quality. Moreover, cost savings are 
possible, as time consuming manual planning by dosimetrists can be avoided.
Feasibility of high quality automated contouring and planning has been demonstrated, 
which is also highly relevant for the rapidly evolving eld of adaptive daily re-planning. 
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